{"filepath": "../L2M3_data/0_csd_related_papers/ACS_XML/am7b09227.xml", "publisher": "acs", "elements": [{"idx": 1, "type": "text", "classification": ["property"], "content": "<p>Drug\ndelivery in target regions could make extraordinary progress in chemoselective\ntherapies. A novel preferred coordination (PC) strategy referring\nto proactive interacting with open active sites to replace previous\noccupation by ion-exchange for controlling release of drug molecules\nis well-constructed. Two topological types of <bold>MOF</bold>-<bold>In1</bold> (Schla\u0308fli symbol: (4,8)-connected of (4<sup>10</sup>\u00b76<sup>15</sup>\u00b78<sup>3</sup>)\u00ad(4<sup>5</sup>\u00b76)<sub>2</sub>) and <bold>MOF</bold>-<bold>In2</bold> (Schla\u0308fli symbol:\n(4,4)-connected of (6<sup>6</sup>)) show the specific way. Increasing\nnode connectivity as well as the trapping of guest OH<sup>\u2013</sup> anions, 5-fluorouracil (5-FU) is preferentially captured into the <bold>MOF</bold>-<bold>In1</bold>, which exhibits an outstanding loading\ncapacity around 34.32 wt %. <sup>19</sup>F NMR spectroscopy was further\nemployed to investigate host\u2013guest interaction and reveal the\nbinding constant (<italic>K</italic>\n<sub>a</sub> = 3.84 \u00d7 10<sup>2</sup> M<sup>\u20131</sup>). Meanwhile, the controlled release\nof 5-FU in a simulated human body with liquid phosphate-buffered saline\nsolution by biofriendly Zn<sup>2+</sup>-triggered is realized. With\nan elevated Zn<sup>2+</sup> concentration, the drug release will be\nenhanced. This efficient strategy for MOFs as multifunctional drug\ncarrier opens a new avenue for biological and medical applications.</p>", "clean_text": "Drug delivery in target regions could make extraordinary progress in chemoselective therapies. A novel preferred coordination (PC) strategy referring to proactive interacting with open active sites to replace previous occupation by ion-exchange for controlling release of drug molecules is well-constructed. Two topological types of MOF-In1 (Schla\u0308fli symbol: (4,8)-connected of (410\u22c5615\u22c583)(45\u22c56)2) and MOF-In2 (Schla\u0308fli symbol: (4,4)-connected of (66)) show the specific way. Increasing node connectivity as well as the trapping of guest OH- anions, 5-fluorouracil (5-FU) is preferentially captured into the MOF-In1, which exhibits an outstanding loading capacity around 34.32 wt %. 19F NMR spectroscopy was further employed to investigate host-guest interaction and reveal the binding constant (K a = 3.84 \u00d7 102 M-1). Meanwhile, the controlled release of 5-FU in a simulated human body with liquid phosphate-buffered saline solution by biofriendly Zn2+-triggered is realized. With an elevated Zn2+ concentration, the drug release will be enhanced. This efficient strategy for MOFs as multifunctional drug carrier opens a new avenue for biological and medical applications.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 2, "type": "text", "classification": ["else"], "content": "<title>Introduction</title><p>To achieve ideal therapeutic effect, traditional\nsmall molecule drugs are usually at a high concentration in the circulation\nof the bloodstream and subsequently reach a desired final concentration\nfor the target tissue. This practice inevitably brings about some\ndefects, including poor solubility and nonselective drug distribution,\nwhich may damage the healthy tissues and limit the therapeutic effect.\nRecently, in the drug delivery field, some chemists have been devoted\nto overcoming these negative effects. Generally, to ensure efficient therapy, drug carriers are required\nnot only to capture drugs with high payloads, but also are hoped to\nbe in nanoscale, which facilitates the release of drugs to the whole\nbody and absorbed by the specific tissues by intravenous administration.\nDifferent from most of the existing pure organic and inorganic carrier\nmaterials, metal organic frameworks (MOFs) as novel porous functionality\nmaterials possess the well-defined pore structure and the open active sites,\nwhich are conducive to binding or transporting specific guests within\nthe frameworks. Thus, it is possible to improve drug solubility issues by choosing\nappropriate nano-MOFs as drug carrier to ensure a targeted delivery.</p>", "clean_text": "Introduction\n\nTo achieve ideal therapeutic effect, traditional small molecule drugs are usually at a high concentration in the circulation of the bloodstream and subsequently reach a desired final concentration for the target tissue. This practice inevitably brings about some defects, including poor solubility and nonselective drug distribution, which may damage the healthy tissues and limit the therapeutic effect. Recently, in the drug delivery field, some chemists have been devoted to overcoming these negative effects. Generally, to ensure efficient therapy, drug carriers are required not only to capture drugs with high payloads, but also are hoped to be in nanoscale, which facilitates the release of drugs to the whole body and absorbed by the specific tissues by intravenous administration. Different from most of the existing pure organic and inorganic carrier materials, metal organic frameworks (MOFs) as novel porous functionality materials possess the well-defined pore structure and the open active sites, which are conducive to binding or transporting specific guests within the frameworks. Thus, it is possible to improve drug solubility issues by choosing appropriate nano-MOFs as drug carrier to ensure a targeted delivery.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 3, "type": "text", "classification": "error", "content": "<p>In addition to ensuring above therapeutically level requirements,\nachieving sustained release is an important prerequisite for efficient\nnanoparticulate drug carriers employed to improve drug efficacy and\nsafety. Inspired by host\u2013guest interaction, anionic nano-MOFs can selectively trap cations through ion exchange\nto achieve a controlled drug delivery. Zinc as one of essential trace\nelements in human body, plays \u201cubiquitous biological role\u201d.\nCompared with other organs, the zinc content is the highest in brain.\nIn brain extracellular fluid, zinc concentration is about 500 nM.\nIn some named \u201czinc-containing\u201d neurons, zinc concentration\nmight exceed 1 mM through weak coordination interaction with endogenous\nligand. Thus, zinc displays a strong\ninfluence on central nervous system and\nzinc imbalance may lead to autism spectrum disorders, Parkinson\u2019s\ndisease, epilepsy, schizophrenia and amyotrophic lateral sclerosis. The increased Zn<sup>2+</sup> concentration in these diseases offers\na new avenue for drug delivery to target regions and reduces the limitation\nfor treatment central nervous system disease.</p>", "clean_text": "In addition to ensuring above therapeutically level requirements, achieving sustained release is an important prerequisite for efficient nanoparticulate drug carriers employed to improve drug efficacy and safety. Inspired by host-guest interaction, anionic nano-MOFs can selectively trap cations through ion exchange to achieve a controlled drug delivery. Zinc as one of essential trace elements in human body, plays \"ubiquitous biological role\". Compared with other organs, the zinc content is the highest in brain. In brain extracellular fluid, zinc concentration is about 500 nM. In some named \"zinc-containing\" neurons, zinc concentration might exceed 1 mM through weak coordination interaction with endogenous ligand. Thus, zinc displays a strong influence on central nervous system and zinc imbalance may lead to autism spectrum disorders, Parkinson's disease, epilepsy, schizophrenia and amyotrophic lateral sclerosis. The increased Zn2+ concentration in these diseases offers a new avenue for drug delivery to target regions and reduces the limitation for treatment central nervous system disease.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 4, "type": "text", "classification": ["else"], "content": "<p>Herein, a novel\npreferred coordination (PC) strategy referring to proactive interacting\nwith open active sites to replace previous occupation by ion-exchange\nfor controlling release of drug molecules is constructed. Two topological\ntypes of <bold>MOF</bold>-<bold>In1</bold> (<bold>{H\u00ad[In</bold>\n<sub>\n<bold>3</bold>\n</sub>\n<bold>(TPO)</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>(OH)</bold>\n<sub>\n<bold>4</bold>\n</sub>\n<bold>]\u00b72H</bold>\n<sub>\n<bold>2</bold>\n</sub>\n<bold>O}</bold>\n<sub>\n<bold>\n<italic>n</italic>\n</bold>\n</sub>) and <bold>MOF</bold>-<bold>In2</bold> (<bold>[In\u00ad(TPO)]</bold>\n<sub>\n<bold>\n<italic>n</italic>\n</bold>\n</sub>) are selected to specify\nthe implementation effect of the PC strategy (). <bold>MOF</bold>-<bold>In1</bold> is built\non 8-connected [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] SBUs to form two kinds of 1D square channels with windows\nsize of about 12.503 \u00d7 8.546 and 8.601 \u00d7 6.121 \u00c5<sup>2</sup>, respectively, which displays a (4,8)-connected topology\nnetwork with the Schla\u0308fli symbol of (4<sup>10</sup>\u00b76<sup>15</sup>\u00b78<sup>3</sup>)\u00ad(4<sup>5</sup>\u00b76)<sub>2</sub>. While\nMOF-<bold>In2</bold> possesses 4-connected [InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] SBUs and integrates in a SBUs-by-SBUs way through bridging\ntris\u00ad(para-carboxylphenyl)\u00adphosphine oxide (H<sub>3</sub>TPO) ligands,\ngenerating a 2-fold interpenetrating (4,4)-connected diamond-like\ntopology structure with the Schla\u0308fli symbol of (6<sup>6</sup>). The first type (<bold>MOF</bold>-<bold>In1</bold>) consists of\n8-connected SBUs and open active site is occupied by OH<sup>\u2013</sup> anion, making entire host framework is negatively charged. In the\nsecond type (<bold>MOF</bold>-<bold>In2</bold>), carboxylate TPO<sup>3\u2013</sup> ligand provides all 4-coordination sites in a regular\nmode to interact with metal source and the resulting structure exhibits\nthe <italic>\n<bold>dia</bold>\n</italic> net as a neutral framework.</p>", "clean_text": "Herein, a novel preferred coordination (PC) strategy referring to proactive interacting with open active sites to replace previous occupation by ion-exchange for controlling release of drug molecules is constructed. Two topological types of MOF-In1 ({H[In  3  (TPO)  2  (OH)  4  ]\u22c52H  2  O}   n  ) and MOF-In2 ([In(TPO)]   n  ) are selected to specify the implementation effect of the PC strategy (). MOF-In1 is built on 8-connected [In3(CO2)6(OH)4] SBUs to form two kinds of 1D square channels with windows size of about 12.503 \u00d7 8.546 and 8.601 \u00d7 6.121 \u00c52, respectively, which displays a (4,8)-connected topology network with the Schla\u0308fli symbol of (410\u22c5615\u22c583)(45\u22c56)2. While MOF-In2 possesses 4-connected [InO(CO2)3] SBUs and integrates in a SBUs-by-SBUs way through bridging tris(para-carboxylphenyl)phosphine oxide (H3TPO) ligands, generating a 2-fold interpenetrating (4,4)-connected diamond-like topology structure with the Schla\u0308fli symbol of (66). The first type (MOF-In1) consists of 8-connected SBUs and open active site is occupied by OH- anion, making entire host framework is negatively charged. In the second type (MOF-In2), carboxylate TPO3- ligand provides all 4-coordination sites in a regular mode to interact with metal source and the resulting structure exhibits the  dia  net as a neutral framework.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 5, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Syntheses Route of MOF-In1 and MOF-In2</title>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"am-2017-09227v_0006.tif\"></graphic>\n</fig>", "clean_text": " 1  Syntheses Route of MOF-In1 and MOF-In2   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 6, "type": "text", "classification": "error", "content": "<p>As a result of the node connectivity increasing from (4,4)-connected\nto (4,8)-connected, as well as the trapping of guest OH<sup>\u2013</sup> anions, the framework contains different pore sizes with the overall\ncharge negative or neutral, which could encapsulate or remove guest\nmolecules based on the shape and charge. Driven by the\nabove-mentioned host\u2013guest interaction, 5-fluorouracil (5-FU)\nas one of the broad-spectrum drug molecule is preferentially captured\ninto the <bold>MOF</bold>-<bold>In1</bold> (loading capacity around\n34.32 wt %) as a novel drug delivery system in comparison to the <bold>MOF</bold>-<bold>In2</bold>. <sup>19</sup>F NMR spectroscopy was\nemployed to investigate host\u2013guest interaction and reveal the\nbinding constant (<italic>K</italic>\n<sub>a</sub> = 3.84 \u00d7 10<sup>2</sup> M<sup>\u20131</sup>). Meanwhile, <bold>MOF</bold>-<bold>In1</bold> exhibited outstanding behavior for the controlled release\nof 5-FU in a simulated human body with liquid phosphate-buffered saline\nsolution by appropriate Zn<sup>2+</sup>-triggered. This method provides\na platform to deliver the sufficient quantities of drugs to a target\nregion accurately ().</p>", "clean_text": "As a result of the node connectivity increasing from (4,4)-connected to (4,8)-connected, as well as the trapping of guest OH- anions, the framework contains different pore sizes with the overall charge negative or neutral, which could encapsulate or remove guest molecules based on the shape and charge. Driven by the above-mentioned host-guest interaction, 5-fluorouracil (5-FU) as one of the broad-spectrum drug molecule is preferentially captured into the MOF-In1 (loading capacity around 34.32 wt %) as a novel drug delivery system in comparison to the MOF-In2. 19F NMR spectroscopy was employed to investigate host-guest interaction and reveal the binding constant (K a = 3.84 \u00d7 102 M-1). Meanwhile, MOF-In1 exhibited outstanding behavior for the controlled release of 5-FU in a simulated human body with liquid phosphate-buffered saline solution by appropriate Zn2+-triggered. This method provides a platform to deliver the sufficient quantities of drugs to a target region accurately ().", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 7, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Preferred Coordination Strategy for Creating <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> and <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold>\n</title>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"am-2017-09227v_0007.tif\"></graphic>\n</fig>", "clean_text": " 2  Preferred Coordination Strategy for Creating 5-FU@MOF-In1 and Zn  2+  @MOF-In1    ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 8, "type": "text", "classification": ["else"], "content": "<title>Results and Discussion</title><title>Structural\nDescription of <bold>MOF-In1</bold>\n</title><p>The structure of <bold>MOF</bold>-<bold>In1</bold> is determined by single crystal crystallography\nand displays a 3D porous framework. It is crystallized in the Monoclinic <italic>C</italic>2/<italic>c</italic> space group and its asymmetric unit\ncontains one and a half In\u00ad(III) ions, one TPO<sup>3\u2013</sup> anion,\ntwo OH<sup>\u2013</sup> anions, a half H<sub>3</sub>O<sup>+</sup> guest cation, and a half neutral H<sub>2</sub>O guest molecule (). After symmetry\noperation, each 6-coordinated In\u00ad(III) cation is coordinated with four\nindependent TPO<sup>3\u2013</sup> ligands and two OH<sup>\u2013</sup> anions in a octahedron coordination geometry to form a 8-connected\n[In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] secondary\nbuilding unit (SBU) (). For the <italic>C</italic>\n<sub>3</sub>-symmetric TPO<sup>3\u2013</sup> ligands,\ntwo carboxylate groups are coordinated in the chelating mode to link\ntwo [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] SBUs,\none remaining carboxylate group and the oxygen atom (O1) from P\ue5fbO\nbond are connected to the other two [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] SBUs in monodentate coordination mode,\nin which all the observed bond lengths of In\u2013O range from 2.076(4)\nto 2.183(4) \u00c5 shown in . In this way, the ligands could be deemed to 4-connected nodes with\nquadrilateral geometry. As a result, the structure of <bold>MOF</bold>-<bold>In1</bold> displays a (4,8)-connected topology network with\nthe Schla\u0308fli symbol of (4<sup>10</sup>\u00b76<sup>15</sup>\u00b78<sup>3</sup>)\u00ad(4<sup>5</sup>\u00b76)<sub>2</sub> (b).</p>", "clean_text": "Results and Discussion\n\nStructural Description of MOF-In1 \n\nThe structure of MOF-In1 is determined by single crystal crystallography and displays a 3D porous framework. It is crystallized in the Monoclinic C2/c space group and its asymmetric unit contains one and a half In(III) ions, one TPO3- anion, two OH- anions, a half H3O+ guest cation, and a half neutral H2O guest molecule (). After symmetry operation, each 6-coordinated In(III) cation is coordinated with four independent TPO3- ligands and two OH- anions in a octahedron coordination geometry to form a 8-connected [In3(CO2)6(OH)4] secondary building unit (SBU) (). For the C 3-symmetric TPO3- ligands, two carboxylate groups are coordinated in the chelating mode to link two [In3(CO2)6(OH)4] SBUs, one remaining carboxylate group and the oxygen atom (O1) from P\ue5fbO bond are connected to the other two [In3(CO2)6(OH)4] SBUs in monodentate coordination mode, in which all the observed bond lengths of In-O range from 2.076(4) to 2.183(4) \u00c5 shown in . In this way, the ligands could be deemed to 4-connected nodes with quadrilateral geometry. As a result, the structure of MOF-In1 displays a (4,8)-connected topology network with the Schla\u0308fli symbol of (410\u22c5615\u22c583)(45\u22c56)2 (b).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>\n<bold>MOF</bold>-<bold>In1</bold> showing (a)\n3D framework containing two types of channels (left, type A; right,\ntype B); (b) 3D topology structure; (c) natural tiling structure.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"am-2017-09227v_0009.tif\"></graphic>\n</fig>", "clean_text": " 1   MOF-In1 showing (a) 3D framework containing two types of channels (left, type A; right, type B); (b) 3D topology structure; (c) natural tiling structure.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 10, "type": "table", "classification": null, "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystal Data and\nStructure Refinement for the Two MOFs</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"3\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>MOF</bold>-<bold>In1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>MOF</bold>-<bold>In2</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>42</sub>H<sub>33</sub>O<sub>20</sub>P<sub>2</sub>In<sub>3</sub>\n</oasis:entry>\n<oasis:entry>C<sub>21</sub>H<sub>12</sub>O<sub>7</sub>PIn</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>form wt</oasis:entry>\n<oasis:entry>1264.08</oasis:entry>\n<oasis:entry>522.10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cryst syst</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>hexagonal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic>C</italic>2/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>R</italic>3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>28.825(6)</oasis:entry>\n<oasis:entry>14.1755(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>11.472(2)</oasis:entry>\n<oasis:entry>14.1755(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>18.905(4)</oasis:entry>\n<oasis:entry>9.5058(11)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>106.62(3)</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n<oasis:entry>120.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>5991(2)</oasis:entry>\n<oasis:entry>1654.2(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>Z</italic>\n</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>D</italic>\n<sub>c</sub> (g\u00a0cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.402</oasis:entry>\n<oasis:entry>1.572</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc (Mo K\u03b1) (mm<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>1.260</oasis:entry>\n<oasis:entry>1.182</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>F</italic>(000)</oasis:entry>\n<oasis:entry>2488</oasis:entry>\n<oasis:entry>774</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cryst size (mm)</oasis:entry>\n<oasis:entry>0.28 \u00d7\n0.26 \u00d7 0.24</oasis:entry>\n<oasis:entry>0.30 \u00d7 0.24 \u00d7 0.23</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b8 range (deg)</oasis:entry>\n<oasis:entry>1.47 to 27.52</oasis:entry>\n<oasis:entry>2.71 to 27.52</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>limiting indices</oasis:entry>\n<oasis:entry>\u201336 \u2264 <italic>h</italic> \u2264 37</oasis:entry>\n<oasis:entry>\u201318 \u2264 <italic>h</italic> \u2264 12</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201314 \u2264 <italic>k</italic> \u2264\n14</oasis:entry>\n<oasis:entry>\u201318 \u2264 <italic>k</italic> \u2264 18</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201323 \u2264 <italic>l</italic> \u2264 23</oasis:entry>\n<oasis:entry>\u201311 \u2264 <italic>l</italic> \u2264 10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>data/restraints/params</oasis:entry>\n<oasis:entry>6603/6/305</oasis:entry>\n<oasis:entry>1579/1/91</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF on <italic>F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.072</oasis:entry>\n<oasis:entry>1.004</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>final <italic>R</italic> indices [<italic>I</italic> &gt; 2\u03c3(<italic>I</italic>)]</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>\n<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0526</oasis:entry>\n<oasis:entry>0.0199</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub>\n<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.1798</oasis:entry>\n<oasis:entry>0.0428</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic> indices (all data)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>\n</oasis:entry>\n<oasis:entry>0.0647</oasis:entry>\n<oasis:entry>0.0199</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub>\n</oasis:entry>\n<oasis:entry>0.1944</oasis:entry>\n<oasis:entry>0.0428</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>largest diff. peak and hole(e\u00b7\u00c5<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>2.835 and \u22121.248</oasis:entry>\n<oasis:entry>0.417 and \u22120.252</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>CCDC</oasis:entry>\n<oasis:entry>1554083</oasis:entry>\n<oasis:entry>1554084</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic>R</italic>\n<sub>1</sub> = \u2211||<italic>F</italic>\n<sub>o</sub>| \u2013 |<italic>F</italic>\n<sub>c</sub>||/\u2211|<italic>F</italic>\n<sub>o</sub>|;</p>\n</fn>\n<fn id=\"t1fn2\">\n<label>b</label>\n<p>\n<italic>wR</italic>\n<sub>2</sub> = [\u2211[<italic>w</italic> (<italic>F</italic>\n<sub>0</sub>\n<sup>2</sup>\u2013 <italic>F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/\u2211[ <italic>w</italic> (<italic>F</italic>\n<sub>0</sub>\n<sup>2</sup>)<sup>2</sup>]]<sup>1/2</sup>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 11, "type": "text", "classification": ["property"], "content": "<p>In this 3D structure, <bold>MOF</bold>-<bold>In1</bold> exhibits two types of 1D square channels\ndivided by these [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] SBUs via alternating the organic linker molecules rotational\norientation along the <italic>b</italic> axis. As depicted in a, two types of 1D\nchannels adopt the ABAB connection mode, with the compositions of\nfour [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>]\nSBUs (A) and two [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] SBUs (B). Under careful observation, there exist open Lewis\nbasic oxygen active sites in the Type A channel, H<sub>3</sub>O<sup>+</sup> and H<sub>2</sub>O guest molecules in the Type B channel,\nrespectively. Calculated using the PLATON program shows the overall\nsolvent-accessible volume equal to 2240.6 \u00c5<sup>3</sup> per unit\ncell, which accounts for about 37.4% of the cell volume of 5991.0\n\u00c5<sup>3</sup> (c).</p>", "clean_text": "In this 3D structure, MOF-In1 exhibits two types of 1D square channels divided by these [In3(CO2)6(OH)4] SBUs via alternating the organic linker molecules rotational orientation along the b axis. As depicted in a, two types of 1D channels adopt the ABAB connection mode, with the compositions of four [In3(CO2)6(OH)4] SBUs (A) and two [In3(CO2)6(OH)4] SBUs (B). Under careful observation, there exist open Lewis basic oxygen active sites in the Type A channel, H3O+ and H2O guest molecules in the Type B channel, respectively. Calculated using the PLATON program shows the overall solvent-accessible volume equal to 2240.6 \u00c53 per unit cell, which accounts for about 37.4% of the cell volume of 5991.0 \u00c53 (c).", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 12, "type": "text", "classification": ["property"], "content": "<title>Structural Description of <bold>MOF-In2</bold>\n</title><p>The study reveals <bold>MOF</bold>-<bold>In2</bold> is\ncrystallized in the Hexagonal <italic>R</italic>3 space group and\nfeatures an [InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] SBU-based 3D diamondlike\nframework. In its asymmetric unit, there is one In\u00ad(III) ion and one\nTPO<sup>3\u2013</sup> anion. Metal In\u00ad(III) ion adopts typical 7-coordinated\ngeometry by six oxygen atoms (chelating coordination mode) from three\ncarboxylate groups of three individual TPO<sup>3\u2013</sup> ligands\n(), as well as one oxygen atom\n(monodentate coordination mode) from the P\ue5fbO of the fourth\nTPO<sup>3\u2013</sup> ligand to give 4-conneceted mononuclear [InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] SBUs, in which the observed In\u2013O bond\nlengths are comparable with those reported. After symmetry\noperation, the ligands joint four [InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] SBUs in four directions and are equal 4-connected nodes. The overall\nstructure of MOF-In2, integrated in a SBUs-by-SBUs way through these\nbridging TPO<sup>3\u2013</sup> ligands, generates a well-constructed\n3D 2-fold interpenetrating diamond-like topology structure with the\nSchla\u0308fli symbol of (6<sup>6</sup>) (). Usually interpenetrating structure minimizes\npore sizes and restricts porosity. The PLATON calculation shows the\noverall solvent-accessible volume equal to 296.0 \u00c5<sup>3</sup> per unit cell, which accounts for about 17.9% of the cell volume\nof 1654.2 \u00c5<sup>3</sup>.</p>", "clean_text": "Structural Description of MOF-In2 \n\nThe study reveals MOF-In2 is crystallized in the Hexagonal R3 space group and features an [InO(CO2)3] SBU-based 3D diamondlike framework. In its asymmetric unit, there is one In(III) ion and one TPO3- anion. Metal In(III) ion adopts typical 7-coordinated geometry by six oxygen atoms (chelating coordination mode) from three carboxylate groups of three individual TPO3- ligands (), as well as one oxygen atom (monodentate coordination mode) from the P\ue5fbO of the fourth TPO3- ligand to give 4-conneceted mononuclear [InO(CO2)3] SBUs, in which the observed In-O bond lengths are comparable with those reported. After symmetry operation, the ligands joint four [InO(CO2)3] SBUs in four directions and are equal 4-connected nodes. The overall structure of MOF-In2, integrated in a SBUs-by-SBUs way through these bridging TPO3- ligands, generates a well-constructed 3D 2-fold interpenetrating diamond-like topology structure with the Schla\u0308fli symbol of (66) (). Usually interpenetrating structure minimizes pore sizes and restricts porosity. The PLATON calculation shows the overall solvent-accessible volume equal to 296.0 \u00c53 per unit cell, which accounts for about 17.9% of the cell volume of 1654.2 \u00c53.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['property']"}}, {"idx": 13, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>\n<bold>MOF</bold>-<bold>In2</bold> showing (a)\n[InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] hexagonal cage; (b) 2D layer; (c)\n3D framework; (d) 3D 2-fold interpenetrating diamondlike topology\nstructure.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"am-2017-09227v_0010.tif\"></graphic>\n</fig>", "clean_text": " 2   MOF-In2 showing (a) [InO(CO2)3] hexagonal cage; (b) 2D layer; (c) 3D framework; (d) 3D 2-fold interpenetrating diamondlike topology structure.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 14, "type": "text", "classification": "error", "content": "<title>Drug Delivery</title><p>Given the channel size and the accessible porosity, <bold>MOF</bold>-<bold>In1</bold> and <bold>MOF</bold>-<bold>In2</bold> are potential\ncandidates in encapsulation of small drug molecules. 5-Fluorouracil\n(5-FU, 5.3 \u00d7 5.0 \u00c5<sup>2</sup>) is a widely used drug molecule\nand selected as a drug model in this drug delivery study. The drug-delivery capacity of the two <bold>MOFs</bold> was evaluated\nby impregnating desolvated <bold>MOF</bold>-<bold>In1</bold> and <bold>MOF</bold>-<bold>In2</bold> (20 mg) respectively, in 5 mL methanol\nsolution containing 5-FU (30 mg) with stirring, and investigated the\nencapsulation of 5-FU into them by UV\u2013vis spectroscopy. As\nshown in a,\nthe entry of 5-FU into the framework of <bold>MOF</bold>-<bold>In1</bold> leads to the decrease of adsorption intensity obviously. However, <bold>MOF</bold>-<bold>In2</bold> did\nnot show obviously 5-FU adsorption properties. The encapsulation of\n5-FU drug molecule into the framework of <bold>MOF</bold>-<bold>In1</bold> is verified by IR spectra (b) via the <italic>v</italic>(C\u2013H) at 3133 cm<sup>\u20131</sup> and the \u2013 O\u2013C\u2013O\u2013 group\nvibrational band between 1684 and 1377 cm<sup>\u20131</sup>. In\naddition, the fluorine atom on the ring absorption band is about at\n1247 cm<sup>\u20131</sup>. The shift\nof carboxylic group <italic>v</italic>(C\ue5fbO) vibrational band\nof drug molecule from 1667 to 1684 cm<sup>\u20131</sup> related\nto the <italic>v</italic>(O\u2013H) vibrational band of <bold>MOF</bold>-<bold>In1</bold> from 3195 to 3130 cm<sup>\u20131</sup>, resulted\nfrom the influence of host\u2013guest interaction between 5-FU and <bold>MOF</bold>-<bold>In1</bold>.</p>", "clean_text": "Drug Delivery\n\nGiven the channel size and the accessible porosity, MOF-In1 and MOF-In2 are potential candidates in encapsulation of small drug molecules. 5-Fluorouracil (5-FU, 5.3 \u00d7 5.0 \u00c52) is a widely used drug molecule and selected as a drug model in this drug delivery study. The drug-delivery capacity of the two MOFs was evaluated by impregnating desolvated MOF-In1 and MOF-In2 (20 mg) respectively, in 5 mL methanol solution containing 5-FU (30 mg) with stirring, and investigated the encapsulation of 5-FU into them by UV-vis spectroscopy. As shown in a, the entry of 5-FU into the framework of MOF-In1 leads to the decrease of adsorption intensity obviously. However, MOF-In2 did not show obviously 5-FU adsorption properties. The encapsulation of 5-FU drug molecule into the framework of MOF-In1 is verified by IR spectra (b) via the v(C-H) at 3133 cm-1 and the - O-C-O- group vibrational band between 1684 and 1377 cm-1. In addition, the fluorine atom on the ring absorption band is about at 1247 cm-1. The shift of carboxylic group v(C\ue5fbO) vibrational band of drug molecule from 1667 to 1684 cm-1 related to the v(O-H) vibrational band of MOF-In1 from 3195 to 3130 cm-1, resulted from the influence of host-guest interaction between 5-FU and MOF-In1.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>(a) UV\u2013vis spectroscopy of <bold>MOF</bold>-<bold>In1</bold> (black) and <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> (red). (b) Infrared spectroscopy of 5-FU, <bold>MOF</bold>-<bold>In1</bold>, and <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"am-2017-09227v_0011.tif\"></graphic>\n</fig>", "clean_text": " 3  (a) UV-vis spectroscopy of MOF-In1 (black) and 5-FU@MOF-In1 (red). (b) Infrared spectroscopy of 5-FU, MOF-In1, and 5-FU@MOF-In1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 16, "type": "text", "classification": "error", "content": "<p>A common strategy to achieve effective\ndrug delivery is to scale down drug-carrying material to the nanometer\nsize. As shown in a, the nanocrystalline <bold>MOF</bold>-<bold>In1</bold> was prepared by a reflux method at low temperature and\ncharacterized by the scanning electron microscope (SEM). The PXRD\nreflection of the obtained nanocrystalline <bold>MOF</bold>-<bold>In1</bold> corresponds well with the simulated pattern, readily indexing\nhigh crystallinity of the obtained <bold>MOF</bold>-<bold>In1</bold> nanomaterial (). Because of\nthe open O\u2013H sites in the channel of <bold>MOF</bold>-<bold>In1</bold> nanocrystalline and its small particle size of about 190\nnm, the <bold>MOF</bold>-<bold>In1</bold> is preferred as drug carrier\nby conjugation with the targeted agent 5-FU to form nanocomposite <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> (b). Further evidence for the uniformly distribution\nof In and F components in the <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> is identified by the elemental mapping. As shown in c, d, the elemental\nmapping images of In and F clearly demonstrate the <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> nanoparticles are homogeneous distribution\nin the 3D framework. The diameters are calculated to be 256 nm for <bold>MOF</bold>-<bold>In1</bold> and 295 nm for <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> (in methanol solution) by dynamic light scattering\n(DLS) (), which shows the particle\nsize became larger after encapsulation 5-FU drug molecules. The particle\ndiameters of <bold>MOF</bold>-<bold>In1</bold> and <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> are also larger than that measured\nby SEM. This phenomenon can ascribe to the exact real diameter are\nreplaced by the hydration diameter. Meanwhile, the zeta potentials\nof <bold>MOF</bold>-<bold>In1</bold> and <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> are measured to be ca. \u221230.6 and \u221221.2\nmV, respectively (), which indicate\nthat <bold>MOF</bold>-<bold>In1</bold> is capable of encapsulation\n5-FU and <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> can maintain\ncertain stability. The loading procedure followed the literature to\nimmerse the nanoparticles in a methanol solution of 5-FU for 1 day.\nThe structure of <bold>MOF</bold>-<bold>In1</bold> possesses two pores\nand the pore diameters are approximately 0.776 and 1.147 nm, respectively\n(). After encapsulation 5-FU molecules, <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> shows the two pore\ndiameters are 0.498 and 0.848 nm, which are smaller than that of <bold>MOF</bold>-<bold>In1</bold>. The smaller pore volume can be attributed\nto the aggregation of 5-FU molecules in the framework of <bold>MOF</bold>-<bold>In1</bold>. The loading amount was determined by thermogravimetric\nanalysis (TGA) and the result showed 34.32 wt % 5-FU uptake, which\ncorresponds to 5 molecules of 5-FU per formula unit of <bold>MOF</bold>-<bold>In1</bold> ().</p>", "clean_text": "A common strategy to achieve effective drug delivery is to scale down drug-carrying material to the nanometer size. As shown in a, the nanocrystalline MOF-In1 was prepared by a reflux method at low temperature and characterized by the scanning electron microscope (SEM). The PXRD reflection of the obtained nanocrystalline MOF-In1 corresponds well with the simulated pattern, readily indexing high crystallinity of the obtained MOF-In1 nanomaterial (). Because of the open O-H sites in the channel of MOF-In1 nanocrystalline and its small particle size of about 190 nm, the MOF-In1 is preferred as drug carrier by conjugation with the targeted agent 5-FU to form nanocomposite 5-FU@MOF-In1 (b). Further evidence for the uniformly distribution of In and F components in the 5-FU@MOF-In1 is identified by the elemental mapping. As shown in c, d, the elemental mapping images of In and F clearly demonstrate the 5-FU@MOF-In1 nanoparticles are homogeneous distribution in the 3D framework. The diameters are calculated to be 256 nm for MOF-In1 and 295 nm for 5-FU@MOF-In1 (in methanol solution) by dynamic light scattering (DLS) (), which shows the particle size became larger after encapsulation 5-FU drug molecules. The particle diameters of MOF-In1 and 5-FU@MOF-In1 are also larger than that measured by SEM. This phenomenon can ascribe to the exact real diameter are replaced by the hydration diameter. Meanwhile, the zeta potentials of MOF-In1 and 5-FU@MOF-In1 are measured to be ca. -30.6 and -21.2 mV, respectively (), which indicate that MOF-In1 is capable of encapsulation 5-FU and 5-FU@MOF-In1 can maintain certain stability. The loading procedure followed the literature to immerse the nanoparticles in a methanol solution of 5-FU for 1 day. The structure of MOF-In1 possesses two pores and the pore diameters are approximately 0.776 and 1.147 nm, respectively (). After encapsulation 5-FU molecules, 5-FU@MOF-In1 shows the two pore diameters are 0.498 and 0.848 nm, which are smaller than that of MOF-In1. The smaller pore volume can be attributed to the aggregation of 5-FU molecules in the framework of MOF-In1. The loading amount was determined by thermogravimetric analysis (TGA) and the result showed 34.32 wt % 5-FU uptake, which corresponds to 5 molecules of 5-FU per formula unit of MOF-In1 ().", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>SEM images\nfor (a) <bold>MOF</bold>-<bold>In1</bold> and (b) <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>, corresponding to the elemental mapping\nimage of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> for (c)\nthe indium element and (d) the fluorine element.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"am-2017-09227v_0001.tif\"></graphic>\n</fig>", "clean_text": " 4  SEM images for (a) MOF-In1 and (b) 5-FU@MOF-In1, corresponding to the elemental mapping image of 5-FU@MOF-In1 for (c) the indium element and (d) the fluorine element.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 18, "type": "text", "classification": "error", "content": "<title>Binding Behavior</title><p>The binding stoichiometry between 5-FU\nand <bold>MOF</bold>-<bold>In1</bold> was further determined through\nJob\u2019s method, by using <sup>19</sup>F NMR at 243 K because\nthe variation of the guest chemical shift in <sup>19</sup>F NMR spectra\nis more distinct than in <sup>1</sup>H NMR spectra. As listed in , the resonance of the F atom shifted\nupfield as the molar fraction of <bold>MOF</bold>-<bold>In1</bold> increased (a). A maximum of 0.832 was obtained in the Job\u2019s curve, indicating\na complexation stoichiometry of 1:5 (b), in agreement with the above-mentioned <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> stoichiometry obtained\nfrom the TGA result. Based on the <sup>19</sup>F NMR results, the\ncoefficient value (<italic>n</italic>) and binding constant (<italic>K</italic>\n<sub>a</sub>) were estimated by using the Hill equation:\n<disp-formula id=\"ueq1\">\n<alternatives>\n<graphic xlink:href=\"am-2017-09227v_m001.gif\"></graphic>\n<mml:math display=\"block\">\n<mml:mi>\u03b8</mml:mi>\n<mml:mo>=</mml:mo>\n<mml:mfrac>\n<mml:mrow>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:mi>H</mml:mi>\n<mml:msub>\n<mml:mrow>\n<mml:mi>G</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi>n</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mo stretchy=\"false\">]</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mrow>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:mi>H</mml:mi>\n<mml:msub>\n<mml:mrow>\n<mml:mi>G</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi>n</mml:mi>\n</mml:mrow>\n</mml:msub>\n<mml:mo stretchy=\"false\">]</mml:mo>\n</mml:mrow>\n<mml:mo>+</mml:mo>\n<mml:mrow>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:mi>H</mml:mi>\n<mml:mo stretchy=\"false\">]</mml:mo>\n</mml:mrow>\n</mml:mrow>\n</mml:mfrac>\n</mml:math>\n</alternatives>\n</disp-formula>\n<disp-formula id=\"ueq2\">\n<alternatives>\n<graphic xlink:href=\"am-2017-09227v_m002.gif\"></graphic>\n<mml:math display=\"block\">\n<mml:mo>=</mml:mo>\n<mml:mfrac>\n<mml:mrow>\n<mml:msup>\n<mml:mrow>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:mi>G</mml:mi>\n<mml:mo stretchy=\"false\">]</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">n</mml:mi>\n</mml:mrow>\n</mml:msup>\n</mml:mrow>\n<mml:mrow>\n<mml:msup>\n<mml:mrow>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:mi>G</mml:mi>\n<mml:mo stretchy=\"false\">]</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mi>n</mml:mi>\n</mml:mrow>\n</mml:msup>\n<mml:mo>+</mml:mo>\n<mml:msup>\n<mml:mrow>\n<mml:mo stretchy=\"true\">(</mml:mo>\n<mml:mfrac>\n<mml:mrow>\n<mml:mn>1</mml:mn>\n</mml:mrow>\n<mml:mrow>\n<mml:msub>\n<mml:mrow>\n<mml:mi>K</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">a</mml:mi>\n</mml:mrow>\n</mml:msub>\n</mml:mrow>\n</mml:mfrac>\n<mml:mo stretchy=\"true\">)</mml:mo>\n</mml:mrow>\n<mml:mrow>\n<mml:mi>n</mml:mi>\n</mml:mrow>\n</mml:msup>\n</mml:mrow>\n</mml:mfrac>\n</mml:math>\n</alternatives>\n</disp-formula>\n<disp-formula id=\"ueq3\">\n<alternatives>\n<graphic xlink:href=\"am-2017-09227v_m003.gif\"></graphic>\n<mml:math display=\"block\">\n<mml:mi>log</mml:mi>\n<mml:mrow>\n<mml:mo stretchy=\"true\">(</mml:mo>\n<mml:mfrac>\n<mml:mrow>\n<mml:mi>\u03b8</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mn>1</mml:mn>\n<mml:mo>\u2212</mml:mo>\n<mml:mi>\u03b8</mml:mi>\n</mml:mrow>\n</mml:mfrac>\n<mml:mo stretchy=\"true\">)</mml:mo>\n</mml:mrow>\n<mml:mo>=</mml:mo>\n<mml:mi>n</mml:mi>\n<mml:mi>log</mml:mi>\n<mml:mrow>\n<mml:mo stretchy=\"false\">[</mml:mo>\n<mml:mi>G</mml:mi>\n<mml:mo stretchy=\"false\">]</mml:mo>\n</mml:mrow>\n<mml:mo>+</mml:mo>\n<mml:mi>n</mml:mi>\n<mml:mi>log</mml:mi>\n<mml:mo linebreak=\"nobreak\" lspace=\"0em\" rspace=\".25em\">\u2061</mml:mo>\n<mml:msub>\n<mml:mrow>\n<mml:mi>K</mml:mi>\n</mml:mrow>\n<mml:mrow>\n<mml:mi mathvariant=\"normal\">a</mml:mi>\n</mml:mrow>\n</mml:msub>\n</mml:math>\n</alternatives>\n</disp-formula>In the hill equation, the value of 1 \u2013 \u03b8\ncan be obtained by dividing <sub>\u0394</sub>\u03b4<sub>observed</sub> by the maximum change of chemical shift <sub>\u0394</sub>\u03b4\nin <sup>19</sup>F NMR spectra. The coefficient value (<italic>n</italic>) of <bold>MOF</bold>-<bold>In1</bold> indicates that the guest molecules\nare independently binding. Derived from the Hill function plot of\nthe <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> system (c), a Hill coefficient\n(<italic>n</italic>) of 2.74 indicates a strongly positive cooperative\nbinding mode between 5-FU and <bold>MOF</bold>-<bold>In1</bold>. The\nmeasured apparent association constant <italic>K</italic>\n<sub>a</sub> is 3.84 \u00d7 10<sup>2</sup> M<sup>\u20131</sup>.</p>", "clean_text": "Binding Behavior\n\nThe binding stoichiometry between 5-FU and MOF-In1 was further determined through Job's method, by using 19F NMR at 243 K because the variation of the guest chemical shift in 19F NMR spectra is more distinct than in 1H NMR spectra. As listed in , the resonance of the F atom shifted upfield as the molar fraction of MOF-In1 increased (a). A maximum of 0.832 was obtained in the Job's curve, indicating a complexation stoichiometry of 1:5 (b), in agreement with the above-mentioned 5-FU@MOF-In1 stoichiometry obtained from the TGA result. Based on the 19F NMR results, the coefficient value (n) and binding constant (K a) were estimated by using the Hill equation:     \u03b8 =   [ H   G   n   ]    [ H   G   n   ]  +  [ H ]           =     [ G ]   n       [ G ]   n   +   (   1     K   a     )   n            log  (   \u03b8   1 - \u03b8   )  = n log  [ G ]  + n log \u2061   K   a     In the hill equation, the value of 1 - \u03b8 can be obtained by dividing \u0394\u03b4observed by the maximum change of chemical shift \u0394\u03b4 in 19F NMR spectra. The coefficient value (n) of MOF-In1 indicates that the guest molecules are independently binding. Derived from the Hill function plot of the 5-FU@MOF-In1 system (c), a Hill coefficient (n) of 2.74 indicates a strongly positive cooperative binding mode between 5-FU and MOF-In1. The measured apparent association constant K a is 3.84 \u00d7 102 M-1.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 19, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>(a) Chemical shift change\nof 5-FU in <sup>19</sup>F NMR spectra (CD<sub>3</sub>OD, 243 K) of <bold>5-FU@MOF-In1</bold> with different molar fractions of 5-FU (\u03c7<sub>5\u2011FU</sub>). (b) Job plot between <bold>MOF-In1</bold> and\n5-FU in CD<sub>3</sub>OD at 243 K showing a maximum at 0.832. (c)\nHill function plot of log\u00ad[(1 \u2013 \u03b8)/\u03b8] vs log\u00ad[5-FU].</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"am-2017-09227v_0002.tif\"></graphic>\n</fig>", "clean_text": " 5  (a) Chemical shift change of 5-FU in 19F NMR spectra (CD3OD, 243 K) of 5-FU@MOF-In1 with different molar fractions of 5-FU (\u03c75-FU). (b) Job plot between MOF-In1 and 5-FU in CD3OD at 243 K showing a maximum at 0.832. (c) Hill function plot of log[(1 - \u03b8)/\u03b8] vs log[5-FU].   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 20, "type": "text", "classification": "error", "content": "<p>In striking contrast, similar\ntitrations of 5-FU into the solution of <bold>MOF</bold>-<bold>In2</bold> showed no chemical shift of F signals in the <sup>19</sup>F NMR\nspectra. The finding suggests that the structure of <bold>MOF</bold>-<bold>In2</bold> is not suitable to capture 5-FU molecules. The\nwindow of <bold>MOF</bold>-<bold>In2</bold> is approximately 16.598\n\u00d7 16.598 \u00c5<sup>2</sup> in diagonal line, which is larger\nthan those two windows of <bold>MOF</bold>-<bold>In1 (</bold>12.503\n\u00d7 8.546 and 8.601 \u00d7 6.121 \u00c5<sup>2</sup>) and results\nin less steric hindrance of the guest molecule 5-FU. Moreover, the\nstructure of <bold>MOF</bold>-<bold>In2</bold> is 2-fold interpenetrating,\nwhich minimizes pore sizes and restricts porosity. Therefore, the\nobserved binding between 5-FU and <bold>MOF</bold>-<bold>In1</bold> underlines that the size selectivity may be dependent on the channel\nwindow.</p>", "clean_text": "In striking contrast, similar titrations of 5-FU into the solution of MOF-In2 showed no chemical shift of F signals in the 19F NMR spectra. The finding suggests that the structure of MOF-In2 is not suitable to capture 5-FU molecules. The window of MOF-In2 is approximately 16.598 \u00d7 16.598 \u00c52 in diagonal line, which is larger than those two windows of MOF-In1 (12.503 \u00d7 8.546 and 8.601 \u00d7 6.121 \u00c52) and results in less steric hindrance of the guest molecule 5-FU. Moreover, the structure of MOF-In2 is 2-fold interpenetrating, which minimizes pore sizes and restricts porosity. Therefore, the observed binding between 5-FU and MOF-In1 underlines that the size selectivity may be dependent on the channel window.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 21, "type": "text", "classification": "error", "content": "<title>Drug Release</title><p>The drug sustained-release experiment\nwas performed at 37 \u00b0C by dialyzing the drug-loaded <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> against simulated human body\nliquids (phosphate buffered saline pH 7.4) and monitored via luminescence\nspectra. As shown in , the luminescence intensity\n(412 nm) of the <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> increases obviously with the number of 5-FU release increasing,\nwhich shows fast release (within initial 8 h) and has been released\n56.8% after 72 h. Study on the release process, it has a great relationship\nwith the position of the 5-FU molecules in the channels of <bold>MOF</bold>-<bold>In1</bold>. The two 1D channels of <bold>MOF</bold>-<bold>In1</bold> comprising open O\u2013H site, are larger than 5-FU\nmolecule size, which offers favorable advantage to encapsulate a large\nnumber of 5-FU molecules. Thus, there exist two kinds of interactions\nfor 5-FU molecules in the structure of <bold>MOF</bold>-<bold>In1</bold>. One force is primarily dominated by 5-FU\u20135-FU intermolecular\ninteractions according to 5-FU molecules away from the pore walls,\nwhich leads to the fast release of the 5-FU in initial 8 h. However,\nthe other force is the hydrogen bonds and \u03c0\u00b7\u00b7\u00b7\u03c0\nstacking due to the host\u2013guest interactions between 5-FU molecules\nand the framework of <bold>MOF</bold>-<bold>In1</bold>, which results\nin the slow release in the second process. Note that the release rate\nof 5-FU in this system is relative low. After the release of 5-FU\nmolecules, the pore diameters are 0.753 and 0.992 nm, which are larger\nthan that of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> but\nsmaller than that of <bold>MOF</bold>-<bold>In1</bold>. The measurement\nresults demonstrate that the release of 5-FU molecules is incomplete.\nIn addition, the structure of <bold>MOF</bold>-<bold>In1</bold> could\nstill remain the integrity of framework after the release of 5-FU\nmolecules.</p>", "clean_text": "Drug Release\n\nThe drug sustained-release experiment was performed at 37 \u00b0C by dialyzing the drug-loaded 5-FU@MOF-In1 against simulated human body liquids (phosphate buffered saline pH 7.4) and monitored via luminescence spectra. As shown in , the luminescence intensity (412 nm) of the 5-FU@MOF-In1 increases obviously with the number of 5-FU release increasing, which shows fast release (within initial 8 h) and has been released 56.8% after 72 h. Study on the release process, it has a great relationship with the position of the 5-FU molecules in the channels of MOF-In1. The two 1D channels of MOF-In1 comprising open O-H site, are larger than 5-FU molecule size, which offers favorable advantage to encapsulate a large number of 5-FU molecules. Thus, there exist two kinds of interactions for 5-FU molecules in the structure of MOF-In1. One force is primarily dominated by 5-FU-5-FU intermolecular interactions according to 5-FU molecules away from the pore walls, which leads to the fast release of the 5-FU in initial 8 h. However, the other force is the hydrogen bonds and \u03c0\u22c5\u22c5\u22c5\u03c0 stacking due to the host-guest interactions between 5-FU molecules and the framework of MOF-In1, which results in the slow release in the second process. Note that the release rate of 5-FU in this system is relative low. After the release of 5-FU molecules, the pore diameters are 0.753 and 0.992 nm, which are larger than that of 5-FU@MOF-In1 but smaller than that of MOF-In1. The measurement results demonstrate that the release of 5-FU molecules is incomplete. In addition, the structure of MOF-In1 could still remain the integrity of framework after the release of 5-FU molecules.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>(a) Luminescence spectra of 5-FU releasing from <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> in PBS (pH 7.4) with time. (b) Release\nprocess of 5-FU from the <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>.</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"am-2017-09227v_0003.tif\"></graphic>\n</fig>", "clean_text": " 6  (a) Luminescence spectra of 5-FU releasing from 5-FU@MOF-In1 in PBS (pH 7.4) with time. (b) Release process of 5-FU from the 5-FU@MOF-In1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 23, "type": "text", "classification": "error", "content": "<title>Zn<sup>2+</sup> Cation\nExchange with <bold>MOF-In1</bold>\n</title><p>On the basis of anionic\nMOFs usually comprising neutral ligand and metal ion, extra-framework\ncations are often located at the framework pore or infirmly coordinated\nwith host framework through open active sites. Exchanging cations inside the framework with other cations\nmight result in the structure and property change. As expected, Zn<sup>2+</sup> ions have been introduced into the 1D channels of anionic <bold>MOF</bold>-<bold>In1</bold> by soaking the samples in methanol solution\nof nitrate salts of Zn<sup>2+</sup> to obtain anion-exchanged material <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold>. It was found that the luminescence spectrum changed little after\nthe zinc salt treatment (a), demonstrating that Zn\u00ad(NO<sub>3</sub>)<sub>3</sub> has no effect on the luminescent emission of <bold>MOF</bold>-<bold>In1</bold>. Considering <bold>MOF</bold>-<bold>In1</bold> containing open oxygen active site, we performed\nthe X-ray photoelectron spectroscopy (XPS) studies of O 1s on <bold>MOF</bold>-<bold>In1</bold> and <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> to further illustrate the\nexchange behavior. The O 1s peak from free oxygen atoms at 531.35\neV in <bold>MOF</bold>-<bold>In1</bold> is moved to 532.16 after anion-exchange\nwith Zn<sup>2+</sup> ions (b), indicating the formation of the weak bond between\noxygen atoms and Zn<sup>2+</sup> ions in <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold>, which results\nin the change of the electron energy level of ligand and the energy\ntransfer occurs between <bold>MOF</bold>-<bold>In1</bold> and Zn<sup>2+</sup> ions. The intensities of the IR curves (c) for <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> at some peaks\nare relatively weaker than those of <bold>MOF</bold>-<bold>In1</bold>, which are also primarily due to <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup> combination. The inductively coupled plasma (ICP) data of <bold>MOF</bold>-<bold>In1</bold> and <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> are listed in  and show that Zn contents in <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> are\n16.02%. In addition, In<sup>3+</sup> contents in <bold>MOF</bold>-<bold>In1</bold> and <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> are 27.25 and 23.61%, respectively. These results\nindicate that the <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup> ions are\nsuccessfully combined to the framework of <bold>MOF</bold>-<bold>In1</bold>. Meanwhile, the PXRD pattern of the <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> is similar to <bold>MOF</bold>-<bold>In1</bold> (d), which indicate the main frameworks of <bold>MOF</bold>-<bold>In1</bold> are maintained.</p>", "clean_text": "Zn2+ Cation Exchange with MOF-In1 \n\nOn the basis of anionic MOFs usually comprising neutral ligand and metal ion, extra-framework cations are often located at the framework pore or infirmly coordinated with host framework through open active sites. Exchanging cations inside the framework with other cations might result in the structure and property change. As expected, Zn2+ ions have been introduced into the 1D channels of anionic MOF-In1 by soaking the samples in methanol solution of nitrate salts of Zn2+ to obtain anion-exchanged material Zn  2+  @MOF-In1. It was found that the luminescence spectrum changed little after the zinc salt treatment (a), demonstrating that Zn(NO3)3 has no effect on the luminescent emission of MOF-In1. Considering MOF-In1 containing open oxygen active site, we performed the X-ray photoelectron spectroscopy (XPS) studies of O 1s on MOF-In1 and Zn  2+  @MOF-In1 to further illustrate the exchange behavior. The O 1s peak from free oxygen atoms at 531.35 eV in MOF-In1 is moved to 532.16 after anion-exchange with Zn2+ ions (b), indicating the formation of the weak bond between oxygen atoms and Zn2+ ions in Zn  2+  @MOF-In1, which results in the change of the electron energy level of ligand and the energy transfer occurs between MOF-In1 and Zn2+ ions. The intensities of the IR curves (c) for Zn  2+  @MOF-In1 at some peaks are relatively weaker than those of MOF-In1, which are also primarily due to Zn  2+  combination. The inductively coupled plasma (ICP) data of MOF-In1 and Zn  2+  @MOF-In1 are listed in  and show that Zn contents in Zn  2+  @MOF-In1 are 16.02%. In addition, In3+ contents in MOF-In1 and Zn  2+  @MOF-In1 are 27.25 and 23.61%, respectively. These results indicate that the Zn  2+  ions are successfully combined to the framework of MOF-In1. Meanwhile, the PXRD pattern of the Zn  2+  @MOF-In1 is similar to MOF-In1 (d), which indicate the main frameworks of MOF-In1 are maintained.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 24, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>\n<bold>MOF</bold>-<bold>In1</bold> and <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> of (a) luminescence emission spectra; (b) X-ray photoelectron spectroscopy\nof O 1s; (c) infrared spectra; (d) PXRD patterns.</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"am-2017-09227v_0004.tif\"></graphic>\n</fig>", "clean_text": " 7   MOF-In1 and Zn  2+  @MOF-In1 of (a) luminescence emission spectra; (b) X-ray photoelectron spectroscopy of O 1s; (c) infrared spectra; (d) PXRD patterns.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 25, "type": "text", "classification": "error", "content": "<title>Zn<sup>2+</sup> Stimuli-Triggered Drug Release</title><p>Inspired\nby Zn<sup>2+</sup> cations exchanging with <bold>MOF</bold>-<bold>In1</bold>, we imagine overexpressed Zn<sup>2+</sup> ions might serve\nas competitive binding sites to modulate release rate of 5-FU from <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>. Thus, we have immersed <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> in phosphate buffered\nsaline of Zn\u00ad(NO<sub>3</sub>)<sub>3</sub> containing varied Zn<sup>2+</sup> concentrations, ranging from 500 nM to 1 mM, 5 mM, and 10\nmM. The Zn<sup>2+</sup>-triggered drug release was monitored and the\nrelease curves of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> are presented in . When the concentration of Zn<sup>2+</sup> is 500 nM in phosphate\nbuffered saline, 65% of 5-FU molecules are released, demonstrating\nthat Zn<sup>2+</sup> can trigger the system of 5-FU molecules release.\nMeanwhile, the more amounts of 5-FU molecules are released from <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> when Zn<sup>2+</sup> concentration are increased.</p>", "clean_text": "Zn2+ Stimuli-Triggered Drug Release\n\nInspired by Zn2+ cations exchanging with MOF-In1, we imagine overexpressed Zn2+ ions might serve as competitive binding sites to modulate release rate of 5-FU from 5-FU@MOF-In1. Thus, we have immersed 5-FU@MOF-In1 in phosphate buffered saline of Zn(NO3)3 containing varied Zn2+ concentrations, ranging from 500 nM to 1 mM, 5 mM, and 10 mM. The Zn2+-triggered drug release was monitored and the release curves of 5-FU@MOF-In1 are presented in . When the concentration of Zn2+ is 500 nM in phosphate buffered saline, 65% of 5-FU molecules are released, demonstrating that Zn2+ can trigger the system of 5-FU molecules release. Meanwhile, the more amounts of 5-FU molecules are released from 5-FU@MOF-In1 when Zn2+ concentration are increased.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>(a) Release processes of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> operated by competitive binding\nwith varied Zn<sup>2+</sup> concentrations with time at 37 \u00b0C;\n(b) comparison of release rate in different Zn<sup>2+</sup> concentrations.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"am-2017-09227v_0005.tif\"></graphic>\n</fig>", "clean_text": " 8  (a) Release processes of 5-FU@MOF-In1 operated by competitive binding with varied Zn2+ concentrations with time at 37 \u00b0C; (b) comparison of release rate in different Zn2+ concentrations.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 27, "type": "text", "classification": ["else"], "content": "<p>As is known, zinc possesses a\nstrong influence on thecentral nervous system. Thus, this novel strategy\ncould offer significant perspectives for treating central nervous\nsystem diseases: First, because of existing higher Zn<sup>2+</sup> concentrations in the brain, the drug molecules from drug carriers\ncould be delivered to the target regions. Second, the biofriendly\ndrug carriers could not only delivery the effectual medicines but\nalso diminish side effect. Third, based on the different Zn<sup>2+</sup> concentrations in patients, the drug release could be fine-tuned.</p>", "clean_text": "As is known, zinc possesses a strong influence on thecentral nervous system. Thus, this novel strategy could offer significant perspectives for treating central nervous system diseases: First, because of existing higher Zn2+ concentrations in the brain, the drug molecules from drug carriers could be delivered to the target regions. Second, the biofriendly drug carriers could not only delivery the effectual medicines but also diminish side effect. Third, based on the different Zn2+ concentrations in patients, the drug release could be fine-tuned.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 28, "type": "text", "classification": "error", "content": "<p>In addition, external heating as another stimuli-responsive is\nselected to investigate the release process of 5-FU from <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>. Upon increasing temperature,\nthe host\u2013guest interactions between 5-FU and <bold>MOF</bold>-<bold>In1</bold> are weakened, and\nthe released amount of 5-FU molecules is gradually enhanced, as shown\nin . This system displays fast\nand high release at 37 \u00b0C in the initial 3 h. Furthermore, the\nrelease rates of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> by competitive binding with varied Zn<sup>2+</sup> concentrations\nat 40 \u00b0C are obviously higher than that at 37 \u00b0C (). Thus, the result reveals the synergistic\neffect of external heating and Zn<sup>2+</sup>-triggered is more conducive\nto drug release.</p>", "clean_text": "In addition, external heating as another stimuli-responsive is selected to investigate the release process of 5-FU from 5-FU@MOF-In1. Upon increasing temperature, the host-guest interactions between 5-FU and MOF-In1 are weakened, and the released amount of 5-FU molecules is gradually enhanced, as shown in . This system displays fast and high release at 37 \u00b0C in the initial 3 h. Furthermore, the release rates of 5-FU@MOF-In1 by competitive binding with varied Zn2+ concentrations at 40 \u00b0C are obviously higher than that at 37 \u00b0C (). Thus, the result reveals the synergistic effect of external heating and Zn2+-triggered is more conducive to drug release.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 29, "type": "text", "classification": "error", "content": "<p>It is also necessary to investigate the cytotoxicity\nof <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> for its potential\napplication in bioimaging.  shows\nthe effects of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> and 5-FU on the viabilities of HASMC cells using the MTT method.\nAfter HASMC cells were incubated with <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> at various concentrations, the cell viabilities\nreach about 92% at the 50 \u03bcg mL<sup>\u20131</sup> concentration,\nwhich display negligible toxicity for normal human cell. These data\nindicate that our novel drug carrier possesses excellent biocompatibility\nand could give highly efficient and selective treatment for drug delivery.</p>", "clean_text": "It is also necessary to investigate the cytotoxicity of 5-FU@MOF-In1 for its potential application in bioimaging.  shows the effects of 5-FU@MOF-In1 and 5-FU on the viabilities of HASMC cells using the MTT method. After HASMC cells were incubated with 5-FU@MOF-In1 at various concentrations, the cell viabilities reach about 92% at the 50 \u03bcg mL-1 concentration, which display negligible toxicity for normal human cell. These data indicate that our novel drug carrier possesses excellent biocompatibility and could give highly efficient and selective treatment for drug delivery.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 30, "type": "text", "classification": "error", "content": "<title>Conclusion</title><p>In summary, we have demonstrated the effectiveness\nof the PC strategy to control capture and release of drug molecules.\nBecause of the size- and charge-selective\nanion exchange, 5-FU is preferentially captured by <bold>MOF</bold>-<bold>In1.</bold> The <sup>19</sup>F NMR spectroscopy was employed\nto estimate the binding constant (<italic>K</italic>\n<sub>a</sub> =\n3.84 \u00d7 10<sup>2</sup> M<sup>\u20131</sup>) between the 5-FU\nand <bold>MOF</bold>-<bold>In1,</bold> which provides important evidence\nfor the understanding of drug loading (around 34.32 wt %) in agreement\nwith the TGA result. In addition, Zn<sup>2+</sup>-triggered drug release\nin phosphate buffered saline also exhibits an excellent method for\ncentral nervous system diseases treatment. These results revealed\nthe great potential of MOFs as an ideal nanomaterial for drug delivery,\nand we envision that this new targeted drug delivery system will have\nincreased biological and medical applications.</p>", "clean_text": "Conclusion\n\nIn summary, we have demonstrated the effectiveness of the PC strategy to control capture and release of drug molecules. Because of the size- and charge-selective anion exchange, 5-FU is preferentially captured by MOF-In1. The 19F NMR spectroscopy was employed to estimate the binding constant (K a = 3.84 \u00d7 102 M-1) between the 5-FU and MOF-In1, which provides important evidence for the understanding of drug loading (around 34.32 wt %) in agreement with the TGA result. In addition, Zn2+-triggered drug release in phosphate buffered saline also exhibits an excellent method for central nervous system diseases treatment. These results revealed the great potential of MOFs as an ideal nanomaterial for drug delivery, and we envision that this new targeted drug delivery system will have increased biological and medical applications.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else]"}}, {"idx": 31, "type": "text", "classification": ["synthesis condition"], "content": "<title>Experimental\nSection</title><title>Synthesis of {H\u00ad[In<sub>3</sub>(TPO)<sub>2</sub>(OH)<sub>4</sub>]\u00b72H<sub>2</sub>O}<sub>\n<italic>n</italic>\n</sub>\n<bold>(MOF-In1)</bold>\n</title><p>A mixture of In\u00ad(NO<sub>3</sub>)<sub>3</sub> (0.1206 g)\nand tris\u00ad(para-carboxylphenyl)\u00adphosphine oxide (H<sub>3</sub>TPO) (0.0413\ng) having a molar ratio of about 4:1 is dissolved in CH<sub>3</sub>CN solvent (2 mL) with pH 2.2 by addition of HNO<sub>3</sub>. While\nstirring for 30 min in air, it was heated at 85 \u00b0C in a Teflon-lined\nstainless steel autoclave (20 mL) for 72 h. With slow cooling, block\ncrystals are obtained at room temperature (yield 67.6% based on H<sub>3</sub>TPO). Elemental anal. Calcd for [C<sub>42</sub>H<sub>33</sub>O<sub>20</sub>P<sub>2</sub>In<sub>3</sub> (<italic>Mr:</italic> 1264.08)]:\nH, 2.63; C, 39.91%. Found: H, 2.65; C, 39.90%. IR (KBr pellet, cm<sup>\u20131</sup>): 3123 (br), 1947 (w), 1773 (w), 1712 (w), 1610 (vs),\n1549 (s), 1381 (vs), 1163 (w), 1109 (m), 1019 (m), 832 (w), 771 (w),\n741 (m), 705 (w), 579 (w), 494 (m), 428 (w). <sup>1</sup>H NMR (400\nMHz, CD<sub>3</sub>OD): \u03b4 = 7.52 (s, 12 H, TPO-<italic>H</italic>\n<sub>3,5,10,12,17,19</sub>), 7.17 (s, 12 H, TPO-<italic>H</italic>\n<sub>2,6,9,13,16,20</sub>), 2.00 (s, 4 H, OH-<italic>H</italic>\n<sub>2,4</sub>) ppm ().</p>", "clean_text": "Experimental Section\n\nSynthesis of {H[In3(TPO)2(OH)4]\u22c52H2O} n  (MOF-In1) \n\nA mixture of In(NO3)3 (0.1206 g) and tris(para-carboxylphenyl)phosphine oxide (H3TPO) (0.0413 g) having a molar ratio of about 4:1 is dissolved in CH3CN solvent (2 mL) with pH 2.2 by addition of HNO3. While stirring for 30 min in air, it was heated at 85 \u00b0C in a Teflon-lined stainless steel autoclave (20 mL) for 72 h. With slow cooling, block crystals are obtained at room temperature (yield 67.6% based on H3TPO). Elemental anal. Calcd for [C42H33O20P2In3 (Mr: 1264.08)]: H, 2.63; C, 39.91%. Found: H, 2.65; C, 39.90%. IR (KBr pellet, cm-1): 3123 (br), 1947 (w), 1773 (w), 1712 (w), 1610 (vs), 1549 (s), 1381 (vs), 1163 (w), 1109 (m), 1019 (m), 832 (w), 771 (w), 741 (m), 705 (w), 579 (w), 494 (m), 428 (w). 1H NMR (400 MHz, CD3OD): \u03b4 = 7.52 (s, 12 H, TPO-H 3,5,10,12,17,19), 7.17 (s, 12 H, TPO-H 2,6,9,13,16,20), 2.00 (s, 4 H, OH-H 2,4) ppm ().", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 32, "type": "text", "classification": ["synthesis condition"], "content": "<title>Synthesis of\n[In\u00ad(TPO)]<sub>\n<italic>n</italic>\n</sub>\n<bold>(MOF-In2)</bold>\n</title><p>A mixture of In\u00ad(NO<sub>3</sub>)<sub>3</sub> (0.6003 g) and H<sub>3</sub>TPO (0.0210 g) having the molar ratio of about 2:1 is dissolved\nin CH<sub>3</sub>CN solvent (6 mL) with pH 3.4 by addition of HNO<sub>3</sub>. While stirring for 30 min in air, it was heated at 120 \u00b0C\nin a Teflon-lined stainless steel autoclave (20 mL) for 120 h. Slowly\ncooling, block crystals are obtained at room temperature (yield 78.6%\nbased on H<sub>3</sub>TPO). Elemental analysis calcd for [C<sub>21</sub>H<sub>12</sub>O<sub>7</sub>PIn (<italic>M</italic>\n<sub>r</sub>\n<italic>:</italic> 522.10)]: H, 2.321; C, 48.3%; found: H, 2.33; C, 48.30%.\nIR (KBr pellet, cm<sup>\u20131</sup>): 3423 (br), 1951 (w), 1827\n(w), 1727 (w), 1586 (m), 1529 (m), 1422 (s), 1206 (s), 1115 (s), 1024\n(s), 884 (vs), 751 (vs), 693 (s), 635 (w), 594 (m), 503 (m), 445 (w)\n(). <sup>1</sup>H NMR (400 MHz,\nCD<sub>3</sub>OD): \u03b4 = 7.43 (s, 6 H, TPO-<italic>H</italic>\n<sub>3,5</sub>), 7.06 (s, 6 H, TPO-<italic>H</italic>\n<sub>2,6</sub>) ppm.</p>", "clean_text": "Synthesis of [In(TPO)] n  (MOF-In2) \n\nA mixture of In(NO3)3 (0.6003 g) and H3TPO (0.0210 g) having the molar ratio of about 2:1 is dissolved in CH3CN solvent (6 mL) with pH 3.4 by addition of HNO3. While stirring for 30 min in air, it was heated at 120 \u00b0C in a Teflon-lined stainless steel autoclave (20 mL) for 120 h. Slowly cooling, block crystals are obtained at room temperature (yield 78.6% based on H3TPO). Elemental analysis calcd for [C21H12O7PIn (M r : 522.10)]: H, 2.321; C, 48.3%; found: H, 2.33; C, 48.30%. IR (KBr pellet, cm-1): 3423 (br), 1951 (w), 1827 (w), 1727 (w), 1586 (m), 1529 (m), 1422 (s), 1206 (s), 1115 (s), 1024 (s), 884 (vs), 751 (vs), 693 (s), 635 (w), 594 (m), 503 (m), 445 (w) (). 1H NMR (400 MHz, CD3OD): \u03b4 = 7.43 (s, 6 H, TPO-H 3,5), 7.06 (s, 6 H, TPO-H 2,6) ppm.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 33, "type": "text", "classification": ["synthesis condition"], "content": "<title>Preparation of Nanoparticle of <bold>MOF-In1</bold> for Drug Carrier</title><p>To load 5-fluorouracil (5-FU) into the channels of <bold>MOF</bold>-<bold>In1</bold>, dehydrated <bold>MOF</bold>-<bold>In1</bold> (20\nmg) is dispersed in a 5-FU (25 mg) containing methanol solution (5\nmL) by a reflux method and stirred for 1 day, yielding ahomogeneous\nlight white solution. The mixtures are then centrifuged (12\u202f000\nr/min for 20 min) and the solid materials are  subsequently washed\nwith chloroform to obtain drug-loaded materials.</p>", "clean_text": "Preparation of Nanoparticle of MOF-In1 for Drug Carrier\n\nTo load 5-fluorouracil (5-FU) into the channels of MOF-In1, dehydrated MOF-In1 (20 mg) is dispersed in a 5-FU (25 mg) containing methanol solution (5 mL) by a reflux method and stirred for 1 day, yielding ahomogeneous light white solution. The mixtures are then centrifuged (12000 r/min for 20 min) and the solid materials are  subsequently washed with chloroform to obtain drug-loaded materials.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['synthesis condition']"}}, {"idx": 34, "type": "text", "classification": ["else"], "content": "<title>Drug Loading\nand Release</title><p>Drug release experiments are carried out by a\npretreated semipermeable dialysis bag (<italic>M</italic>\n<sub>w</sub> = 1000) at 37 \u00b0C with gentle shaking; 10.0 mg of prepared <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> sample is dispersed\nin 8.0 mL of PBS (pH 7.4). In the release process of certain time\ninterval, 1.0 mL of solution is extracted out for measurement and\n1.0 mL of fresh PBS buffer is then refilled.</p>", "clean_text": "Drug Loading and Release\n\nDrug release experiments are carried out by a pretreated semipermeable dialysis bag (M w = 1000) at 37 \u00b0C with gentle shaking; 10.0 mg of prepared 5-FU@MOF-In1 sample is dispersed in 8.0 mL of PBS (pH 7.4). In the release process of certain time interval, 1.0 mL of solution is extracted out for measurement and 1.0 mL of fresh PBS buffer is then refilled.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 35, "type": "text", "classification": ["else"], "content": "<p>The Supporting Information\nis available free of charge on the <ext-link xlink:href=\"http://pubs.acs.org\">ACS Publications website</ext-link> at DOI: <ext-link xlink:href=\"http://pubs.acs.org/doi/abs/10.1021/acsami.7b09227\">10.1021/acsami.7b09227</ext-link>.<list id=\"silist\" list-type=\"label\">\n<list-item>\n<p>Figures S1\u2013S11\nand Tables S1\u2013S6 (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.7b09227/suppl_file/am7b09227_si_001.pdf\">PDF</ext-link>)</p>\n</list-item>\n<list-item>\n<p>Crystallographic information files (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.7b09227/suppl_file/am7b09227_si_002.zip\">ZIP</ext-link>)</p>\n</list-item>\n</list>\n</p>", "clean_text": "The Supporting Information is available free of charge on the ACS Publications website at DOI: 10.1021/acsami.7b09227.  Figures S1-S11 and Tables S1-S6 (PDF)   Crystallographic information files (ZIP)   ", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}, {"idx": 36, "type": "text", "classification": ["else"], "content": "<p>Figures S1\u2013S11\nand Tables S1\u2013S6 (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.7b09227/suppl_file/am7b09227_si_001.pdf\">PDF</ext-link>)</p><p>Crystallographic information files (<ext-link xlink:href=\"http://pubs.acs.org/doi/suppl/10.1021/acsami.7b09227/suppl_file/am7b09227_si_002.zip\">ZIP</ext-link>)</p><p>The authors declare no competing\nfinancial interest.</p>", "clean_text": "Figures S1-S11 and Tables S1-S6 (PDF)\n\nCrystallographic information files (ZIP)\n\nThe authors declare no competing financial interest.", "data": null, "include_properties": null, "intermediate_step": {"categorize": "['else']"}}], "cln_elements": [{"idx": "31, 32, 33", "type": "text", "classification": "synthesis condition", "content": "<title>Experimental\nSection</title><title>Synthesis of {H\u00ad[In<sub>3</sub>(TPO)<sub>2</sub>(OH)<sub>4</sub>]\u00b72H<sub>2</sub>O}<sub>\n<italic>n</italic>\n</sub>\n<bold>(MOF-In1)</bold>\n</title><p>A mixture of In\u00ad(NO<sub>3</sub>)<sub>3</sub> (0.1206 g)\nand tris\u00ad(para-carboxylphenyl)\u00adphosphine oxide (H<sub>3</sub>TPO) (0.0413\ng) having a molar ratio of about 4:1 is dissolved in CH<sub>3</sub>CN solvent (2 mL) with pH 2.2 by addition of HNO<sub>3</sub>. While\nstirring for 30 min in air, it was heated at 85 \u00b0C in a Teflon-lined\nstainless steel autoclave (20 mL) for 72 h. With slow cooling, block\ncrystals are obtained at room temperature (yield 67.6% based on H<sub>3</sub>TPO). Elemental anal. Calcd for [C<sub>42</sub>H<sub>33</sub>O<sub>20</sub>P<sub>2</sub>In<sub>3</sub> (<italic>Mr:</italic> 1264.08)]:\nH, 2.63; C, 39.91%. Found: H, 2.65; C, 39.90%. IR (KBr pellet, cm<sup>\u20131</sup>): 3123 (br), 1947 (w), 1773 (w), 1712 (w), 1610 (vs),\n1549 (s), 1381 (vs), 1163 (w), 1109 (m), 1019 (m), 832 (w), 771 (w),\n741 (m), 705 (w), 579 (w), 494 (m), 428 (w). <sup>1</sup>H NMR (400\nMHz, CD<sub>3</sub>OD): \u03b4 = 7.52 (s, 12 H, TPO-<italic>H</italic>\n<sub>3,5,10,12,17,19</sub>), 7.17 (s, 12 H, TPO-<italic>H</italic>\n<sub>2,6,9,13,16,20</sub>), 2.00 (s, 4 H, OH-<italic>H</italic>\n<sub>2,4</sub>) ppm ().</p><title>Synthesis of\n[In\u00ad(TPO)]<sub>\n<italic>n</italic>\n</sub>\n<bold>(MOF-In2)</bold>\n</title><p>A mixture of In\u00ad(NO<sub>3</sub>)<sub>3</sub> (0.6003 g) and H<sub>3</sub>TPO (0.0210 g) having the molar ratio of about 2:1 is dissolved\nin CH<sub>3</sub>CN solvent (6 mL) with pH 3.4 by addition of HNO<sub>3</sub>. While stirring for 30 min in air, it was heated at 120 \u00b0C\nin a Teflon-lined stainless steel autoclave (20 mL) for 120 h. Slowly\ncooling, block crystals are obtained at room temperature (yield 78.6%\nbased on H<sub>3</sub>TPO). Elemental analysis calcd for [C<sub>21</sub>H<sub>12</sub>O<sub>7</sub>PIn (<italic>M</italic>\n<sub>r</sub>\n<italic>:</italic> 522.10)]: H, 2.321; C, 48.3%; found: H, 2.33; C, 48.30%.\nIR (KBr pellet, cm<sup>\u20131</sup>): 3423 (br), 1951 (w), 1827\n(w), 1727 (w), 1586 (m), 1529 (m), 1422 (s), 1206 (s), 1115 (s), 1024\n(s), 884 (vs), 751 (vs), 693 (s), 635 (w), 594 (m), 503 (m), 445 (w)\n(). <sup>1</sup>H NMR (400 MHz,\nCD<sub>3</sub>OD): \u03b4 = 7.43 (s, 6 H, TPO-<italic>H</italic>\n<sub>3,5</sub>), 7.06 (s, 6 H, TPO-<italic>H</italic>\n<sub>2,6</sub>) ppm.</p><title>Preparation of Nanoparticle of <bold>MOF-In1</bold> for Drug Carrier</title><p>To load 5-fluorouracil (5-FU) into the channels of <bold>MOF</bold>-<bold>In1</bold>, dehydrated <bold>MOF</bold>-<bold>In1</bold> (20\nmg) is dispersed in a 5-FU (25 mg) containing methanol solution (5\nmL) by a reflux method and stirred for 1 day, yielding ahomogeneous\nlight white solution. The mixtures are then centrifuged (12\u202f000\nr/min for 20 min) and the solid materials are  subsequently washed\nwith chloroform to obtain drug-loaded materials.</p>", "clean_text": "Experimental Section\n\nSynthesis of {H[In3(TPO)2(OH)4]\u22c52H2O} n  (MOF-In1) \n\nA mixture of In(NO3)3 (0.1206 g) and tris(para-carboxylphenyl)phosphine oxide (H3TPO) (0.0413 g) having a molar ratio of about 4:1 is dissolved in CH3CN solvent (2 mL) with pH 2.2 by addition of HNO3. While stirring for 30 min in air, it was heated at 85 \u00b0C in a Teflon-lined stainless steel autoclave (20 mL) for 72 h. With slow cooling, block crystals are obtained at room temperature (yield 67.6% based on H3TPO). Elemental anal. Calcd for [C42H33O20P2In3 (Mr: 1264.08)]: H, 2.63; C, 39.91%. Found: H, 2.65; C, 39.90%. IR (KBr pellet, cm-1): 3123 (br), 1947 (w), 1773 (w), 1712 (w), 1610 (vs), 1549 (s), 1381 (vs), 1163 (w), 1109 (m), 1019 (m), 832 (w), 771 (w), 741 (m), 705 (w), 579 (w), 494 (m), 428 (w). 1H NMR (400 MHz, CD3OD): \u03b4 = 7.52 (s, 12 H, TPO-H 3,5,10,12,17,19), 7.17 (s, 12 H, TPO-H 2,6,9,13,16,20), 2.00 (s, 4 H, OH-H 2,4) ppm ().\n\nSynthesis of [In(TPO)] n  (MOF-In2) \n\nA mixture of In(NO3)3 (0.6003 g) and H3TPO (0.0210 g) having the molar ratio of about 2:1 is dissolved in CH3CN solvent (6 mL) with pH 3.4 by addition of HNO3. While stirring for 30 min in air, it was heated at 120 \u00b0C in a Teflon-lined stainless steel autoclave (20 mL) for 120 h. Slowly cooling, block crystals are obtained at room temperature (yield 78.6% based on H3TPO). Elemental analysis calcd for [C21H12O7PIn (M r : 522.10)]: H, 2.321; C, 48.3%; found: H, 2.33; C, 48.30%. IR (KBr pellet, cm-1): 3423 (br), 1951 (w), 1827 (w), 1727 (w), 1586 (m), 1529 (m), 1422 (s), 1206 (s), 1115 (s), 1024 (s), 884 (vs), 751 (vs), 693 (s), 635 (w), 594 (m), 503 (m), 445 (w) (). 1H NMR (400 MHz, CD3OD): \u03b4 = 7.43 (s, 6 H, TPO-H 3,5), 7.06 (s, 6 H, TPO-H 2,6) ppm.\n\nPreparation of Nanoparticle of MOF-In1 for Drug Carrier\n\nTo load 5-fluorouracil (5-FU) into the channels of MOF-In1, dehydrated MOF-In1 (20 mg) is dispersed in a 5-FU (25 mg) containing methanol solution (5 mL) by a reflux method and stirred for 1 day, yielding ahomogeneous light white solution. The mixtures are then centrifuged (12000 r/min for 20 min) and the solid materials are  subsequently washed with chloroform to obtain drug-loaded materials.", "data": [[{"meta": {"name": "{H[In3(TPO)2(OH)4]\u22c52H2O} n", "symbol": "MOF-In1", "chemical formula": "C42H33O20P2In3"}, "processes": [{"synthesis method": "solvothermal synthesis", "precursor": [{"name": "In(NO3)3", "amount": "0.1206", "unit": "g"}, {"name": "tris(para-carboxylphenyl)phosphine oxide (H3TPO)", "amount": "0.0413", "unit": "g"}], "solvent": [{"name": "CH3CN", "amount": "2", "unit": "mL"}], "reducing agent": [{"name": "HNO3", "amount": "", "unit": ""}], "surfactant": [{"name": "", "amount": "", "unit": ""}], "pressure": "", "temperature": "85\u00b0C", "time": "72h", "heating rate": "", "cooling rate": "slow"}, {"synthesis method": "pH adjustment", "pH": "2.2", "modulator": "HNO3"}], "yield": "67.6%"}, {"meta": {"name": "[In(TPO)] n", "symbol": "MOF-In2", "chemical formula": "C21H12O7PIn"}, "processes": [{"synthesis method": "solvothermal synthesis", "precursor": [{"name": "In(NO3)3", "amount": "0.6003", "unit": "g"}, {"name": "H3TPO", "amount": "0.0210", "unit": "g"}], "solvent": [{"name": "CH3CN", "amount": "6", "unit": "mL"}], "reducing agent": [{"name": "HNO3", "amount": "", "unit": ""}], "surfactant": [{"name": "", "amount": "", "unit": ""}], "pressure": "", "temperature": "120\u00b0C", "time": "120h", "heating rate": "", "cooling rate": "slow"}, {"synthesis method": "pH adjustment", "pH": "3.4", "modulator": "HNO3"}], "yield": "78.6%"}, {"meta": {"name": "Nanoparticle of MOF-In1 for Drug Carrier", "symbol": "", "chemical formula": ""}, "processes": [{"synthesis method": "chemical synthesis", "precursor": [{"name": "5-fluorouracil (5-FU)", "amount": "25", "unit": "mg"}, {"name": "dehydrated MOF-In1", "amount": "20", "unit": "mg"}], "solution": [{"name": "methanol", "amount": "5", "unit": "mL"}], "pressure": "", "temperature": "", "time": "1 day"}, {"synthesis method": "centrifugation", "revolution per time": "12000 r/min", "relative centrifugal force": "", "time": "20 min", "temperature": "", "additive": [{"name": "", "amount": "", "unit": ""}], "tube material": "", "tube volume": ""}, {"synthesis method": "washing", "washing solution": "chloroform", "amount": ""}]}]], "include_properties": ["solvothermal_synthesis", "pH_adjustment", "washing", "centrifugation"], "intermediate_step": {"text-synthesis-type": "['solvothermal_synthesis', 'pH_adjustment', 'centrifugation', 'washing']", "text-synthesis-struct": "```JSON\n[{\"meta\":{\"name\":\"{H[In3(TPO)2(OH)4]\u22c52H2O} n\", \"symbol\":\"MOF-In1\", \"chemical formula\":\"C42H33O20P2In3\"}, \"processes\":[{\"synthesis method\": \"solvothermal synthesis\", \"precursor\":[{\"name\":\"In(NO3)3\", \"amount\":\"0.1206\", \"unit\":\"g\"}, {\"name\":\"tris(para-carboxylphenyl)phosphine oxide (H3TPO)\", \"amount\":\"0.0413\", \"unit\":\"g\"}], \"solvent\":[{\"name\":\"CH3CN\", \"amount\":\"2\", \"unit\":\"mL\"}], \"reducing agent\":[{\"name\":\"HNO3\", \"amount\":\"\", \"unit\":\"\"}], \"surfactant\":[{\"name\":\"\", \"amount\":\"\", \"unit\":\"\"}], \"pressure\":\"\", \"temperature\":\"85\u00b0C\", \"time\":\"72h\", \"heating rate\":\"\", \"cooling rate\":\"slow\"}, {\"synthesis method\": \"pH adjustment\", \"pH\": \"2.2\", \"modulator\": \"HNO3\"}], \"yield\":\"67.6%\"}, {\"meta\":{\"name\":\"[In(TPO)] n\", \"symbol\":\"MOF-In2\", \"chemical formula\":\"C21H12O7PIn\"}, \"processes\":[{\"synthesis method\": \"solvothermal synthesis\", \"precursor\":[{\"name\":\"In(NO3)3\", \"amount\":\"0.6003\", \"unit\":\"g\"}, {\"name\":\"H3TPO\", \"amount\":\"0.0210\", \"unit\":\"g\"}], \"solvent\":[{\"name\":\"CH3CN\", \"amount\":\"6\", \"unit\":\"mL\"}], \"reducing agent\":[{\"name\":\"HNO3\", \"amount\":\"\", \"unit\":\"\"}], \"surfactant\":[{\"name\":\"\", \"amount\":\"\", \"unit\":\"\"}], \"pressure\":\"\", \"temperature\":\"120\u00b0C\", \"time\":\"120h\", \"heating rate\":\"\", \"cooling rate\":\"slow\"}, {\"synthesis method\": \"pH adjustment\", \"pH\": \"3.4\", \"modulator\": \"HNO3\"}], \"yield\":\"78.6%\"}, {\"meta\":{\"name\":\"Nanoparticle of MOF-In1 for Drug Carrier\", \"symbol\":\"\", \"chemical formula\":\"\"}, \"processes\":[{\"synthesis method\": \"chemical synthesis\", \"precursor\":[{\"name\":\"5-fluorouracil (5-FU)\", \"amount\":\"25\", \"unit\":\"mg\"}, {\"name\":\"dehydrated MOF-In1\", \"amount\":\"20\", \"unit\":\"mg\"}], \"solution\":[{\"name\":\"methanol\", \"amount\":\"5\", \"unit\":\"mL\"}], \"pressure\":\"\", \"temperature\":\"\", \"time\":\"1 day\"}, {\"synthesis method\": \"centrifugation\", \"revolution per time\":\"12000 r/min\", \"relative centrifugal force\":\"\", \"time\":\"20 min\", \"temperature\":\"\", \"additive\":[{\"name\":\"\", \"amount\":\"\", \"unit\":\"\"}], \"tube material\":\"\", \"tube volume\":\"\"}, {\"synthesis method\":\"washing\", \"washing solution\":\"chloroform\", \"amount\":\"\"}]}]\n```"}}, {"idx": "1, 11, 12", "type": "text", "classification": "property", "content": "<p>Drug\ndelivery in target regions could make extraordinary progress in chemoselective\ntherapies. A novel preferred coordination (PC) strategy referring\nto proactive interacting with open active sites to replace previous\noccupation by ion-exchange for controlling release of drug molecules\nis well-constructed. Two topological types of <bold>MOF</bold>-<bold>In1</bold> (Schla\u0308fli symbol: (4,8)-connected of (4<sup>10</sup>\u00b76<sup>15</sup>\u00b78<sup>3</sup>)\u00ad(4<sup>5</sup>\u00b76)<sub>2</sub>) and <bold>MOF</bold>-<bold>In2</bold> (Schla\u0308fli symbol:\n(4,4)-connected of (6<sup>6</sup>)) show the specific way. Increasing\nnode connectivity as well as the trapping of guest OH<sup>\u2013</sup> anions, 5-fluorouracil (5-FU) is preferentially captured into the <bold>MOF</bold>-<bold>In1</bold>, which exhibits an outstanding loading\ncapacity around 34.32 wt %. <sup>19</sup>F NMR spectroscopy was further\nemployed to investigate host\u2013guest interaction and reveal the\nbinding constant (<italic>K</italic>\n<sub>a</sub> = 3.84 \u00d7 10<sup>2</sup> M<sup>\u20131</sup>). Meanwhile, the controlled release\nof 5-FU in a simulated human body with liquid phosphate-buffered saline\nsolution by biofriendly Zn<sup>2+</sup>-triggered is realized. With\nan elevated Zn<sup>2+</sup> concentration, the drug release will be\nenhanced. This efficient strategy for MOFs as multifunctional drug\ncarrier opens a new avenue for biological and medical applications.</p><p>In this 3D structure, <bold>MOF</bold>-<bold>In1</bold> exhibits two types of 1D square channels\ndivided by these [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] SBUs via alternating the organic linker molecules rotational\norientation along the <italic>b</italic> axis. As depicted in a, two types of 1D\nchannels adopt the ABAB connection mode, with the compositions of\nfour [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>]\nSBUs (A) and two [In<sub>3</sub>(CO<sub>2</sub>)<sub>6</sub>(OH)<sub>4</sub>] SBUs (B). Under careful observation, there exist open Lewis\nbasic oxygen active sites in the Type A channel, H<sub>3</sub>O<sup>+</sup> and H<sub>2</sub>O guest molecules in the Type B channel,\nrespectively. Calculated using the PLATON program shows the overall\nsolvent-accessible volume equal to 2240.6 \u00c5<sup>3</sup> per unit\ncell, which accounts for about 37.4% of the cell volume of 5991.0\n\u00c5<sup>3</sup> (c).</p><title>Structural Description of <bold>MOF-In2</bold>\n</title><p>The study reveals <bold>MOF</bold>-<bold>In2</bold> is\ncrystallized in the Hexagonal <italic>R</italic>3 space group and\nfeatures an [InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] SBU-based 3D diamondlike\nframework. In its asymmetric unit, there is one In\u00ad(III) ion and one\nTPO<sup>3\u2013</sup> anion. Metal In\u00ad(III) ion adopts typical 7-coordinated\ngeometry by six oxygen atoms (chelating coordination mode) from three\ncarboxylate groups of three individual TPO<sup>3\u2013</sup> ligands\n(), as well as one oxygen atom\n(monodentate coordination mode) from the P\ue5fbO of the fourth\nTPO<sup>3\u2013</sup> ligand to give 4-conneceted mononuclear [InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] SBUs, in which the observed In\u2013O bond\nlengths are comparable with those reported. After symmetry\noperation, the ligands joint four [InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] SBUs in four directions and are equal 4-connected nodes. The overall\nstructure of MOF-In2, integrated in a SBUs-by-SBUs way through these\nbridging TPO<sup>3\u2013</sup> ligands, generates a well-constructed\n3D 2-fold interpenetrating diamond-like topology structure with the\nSchla\u0308fli symbol of (6<sup>6</sup>) (). Usually interpenetrating structure minimizes\npore sizes and restricts porosity. The PLATON calculation shows the\noverall solvent-accessible volume equal to 296.0 \u00c5<sup>3</sup> per unit cell, which accounts for about 17.9% of the cell volume\nof 1654.2 \u00c5<sup>3</sup>.</p>", "clean_text": "Drug delivery in target regions could make extraordinary progress in chemoselective therapies. A novel preferred coordination (PC) strategy referring to proactive interacting with open active sites to replace previous occupation by ion-exchange for controlling release of drug molecules is well-constructed. Two topological types of MOF-In1 (Schla\u0308fli symbol: (4,8)-connected of (410\u22c5615\u22c583)(45\u22c56)2) and MOF-In2 (Schla\u0308fli symbol: (4,4)-connected of (66)) show the specific way. Increasing node connectivity as well as the trapping of guest OH- anions, 5-fluorouracil (5-FU) is preferentially captured into the MOF-In1, which exhibits an outstanding loading capacity around 34.32 wt %. 19F NMR spectroscopy was further employed to investigate host-guest interaction and reveal the binding constant (K a = 3.84 \u00d7 102 M-1). Meanwhile, the controlled release of 5-FU in a simulated human body with liquid phosphate-buffered saline solution by biofriendly Zn2+-triggered is realized. With an elevated Zn2+ concentration, the drug release will be enhanced. This efficient strategy for MOFs as multifunctional drug carrier opens a new avenue for biological and medical applications.\n\nIn this 3D structure, MOF-In1 exhibits two types of 1D square channels divided by these [In3(CO2)6(OH)4] SBUs via alternating the organic linker molecules rotational orientation along the b axis. As depicted in a, two types of 1D channels adopt the ABAB connection mode, with the compositions of four [In3(CO2)6(OH)4] SBUs (A) and two [In3(CO2)6(OH)4] SBUs (B). Under careful observation, there exist open Lewis basic oxygen active sites in the Type A channel, H3O+ and H2O guest molecules in the Type B channel, respectively. Calculated using the PLATON program shows the overall solvent-accessible volume equal to 2240.6 \u00c53 per unit cell, which accounts for about 37.4% of the cell volume of 5991.0 \u00c53 (c).\n\nStructural Description of MOF-In2 \n\nThe study reveals MOF-In2 is crystallized in the Hexagonal R3 space group and features an [InO(CO2)3] SBU-based 3D diamondlike framework. In its asymmetric unit, there is one In(III) ion and one TPO3- anion. Metal In(III) ion adopts typical 7-coordinated geometry by six oxygen atoms (chelating coordination mode) from three carboxylate groups of three individual TPO3- ligands (), as well as one oxygen atom (monodentate coordination mode) from the P\ue5fbO of the fourth TPO3- ligand to give 4-conneceted mononuclear [InO(CO2)3] SBUs, in which the observed In-O bond lengths are comparable with those reported. After symmetry operation, the ligands joint four [InO(CO2)3] SBUs in four directions and are equal 4-connected nodes. The overall structure of MOF-In2, integrated in a SBUs-by-SBUs way through these bridging TPO3- ligands, generates a well-constructed 3D 2-fold interpenetrating diamond-like topology structure with the Schla\u0308fli symbol of (66) (). Usually interpenetrating structure minimizes pore sizes and restricts porosity. The PLATON calculation shows the overall solvent-accessible volume equal to 296.0 \u00c53 per unit cell, which accounts for about 17.9% of the cell volume of 1654.2 \u00c53.", "data": [[[{"meta": {"name": "MOF-In1", "symbol": "", "chemical formula": ""}, "gas adsorption": [{"adsorbate": "5-fluorouracil", "adsorbed amount": "34.32", "unit": "wt%", "temperature": "", "pressure": "", "condition": ""}], "porosity": [{"probe": "PLATON program", "value": "37.4", "unit": "%", "condition": "overall solvent-accessible volume equal to 2240.6 \u00c53 per unit cell"}], "topology": [{"value": "(4,8)-connected of (410\u22c5615\u22c583)(45\u22c56)2", "condition": ""}], "space group": []}, {"meta": {"name": "MOF-In2", "symbol": "", "chemical formula": ""}, "gas adsorption": [], "porosity": [{"probe": "PLATON program", "value": "17.9", "unit": "%", "condition": "overall solvent-accessible volume equal to 296.0 \u00c53 per unit cell"}], "topology": [{"value": "(66)", "condition": ""}], "space group": [{"value": "R3", "condition": ""}]}]]], "include_properties": ["gas_adsorption", "porosity", "topology", "space_group"], "intermediate_step": {"categorize": "['property']", "text-property-type": "['gas_adsorption', 'porosity', 'topology', 'space_group']", "text-property-extract": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"MOF-In1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"gas adsorption\": [\n            {\n                \"adsorbate\": \"5-fluorouracil\",\n                \"adsorbed amount\": \"34.32\",\n                \"unit\": \"wt%\",\n                \"temperature\": \"\",\n                \"pressure\": \"\",\n                \"condition\": \"\"\n            }\n        ],\n        \"porosity\": [\n            {\n                \"probe\": \"PLATON program\",\n                \"value\": \"37.4\",\n                \"unit\": \"%\",\n                \"condition\": \"overall solvent-accessible volume equal to 2240.6 \u00c53 per unit cell\"\n            }\n        ],\n        \"topology\": [\n            {\n                \"value\": \"(4,8)-connected of (410\u22c5615\u22c583)(45\u22c56)2\",\n                \"condition\": \"\"\n            }\n        ],\n        \"space group\": []\n    },\n    {\n        \"meta\": {\n            \"name\": \"MOF-In2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"\"\n        },\n        \"gas adsorption\": [],\n        \"porosity\": [\n            {\n                \"probe\": \"PLATON program\",\n                \"value\": \"17.9\",\n                \"unit\": \"%\",\n                \"condition\": \"overall solvent-accessible volume equal to 296.0 \u00c53 per unit cell\"\n            }\n        ],\n        \"topology\": [\n            {\n                \"value\": \"(66)\",\n                \"condition\": \"\"\n            }\n        ],\n        \"space group\": [\n            {\n                \"value\": \"R3\",\n                \"condition\": \"\"\n            }\n        ]\n    }\n]\n```"}}, {"idx": 10, "type": "table", "classification": ["Crystal"], "content": "<table-wrap id=\"tbl1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Crystal Data and\nStructure Refinement for the Two MOFs</title>\n</caption>\n<oasis:table colsep=\"0\" rowsep=\"0\">\n<oasis:tgroup cols=\"3\">\n<oasis:colspec align=\"left\" colname=\"col1\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col2\"></oasis:colspec>\n<oasis:colspec align=\"left\" colname=\"col3\"></oasis:colspec>\n<oasis:thead>\n<oasis:row>\n<oasis:entry align=\"center\"></oasis:entry>\n<oasis:entry align=\"center\">\n<bold>MOF</bold>-<bold>In1</bold>\n</oasis:entry>\n<oasis:entry align=\"center\">\n<bold>MOF</bold>-<bold>In2</bold>\n</oasis:entry>\n</oasis:row>\n</oasis:thead>\n<oasis:tbody>\n<oasis:row>\n<oasis:entry>empirical formula</oasis:entry>\n<oasis:entry>C<sub>42</sub>H<sub>33</sub>O<sub>20</sub>P<sub>2</sub>In<sub>3</sub>\n</oasis:entry>\n<oasis:entry>C<sub>21</sub>H<sub>12</sub>O<sub>7</sub>PIn</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>form wt</oasis:entry>\n<oasis:entry>1264.08</oasis:entry>\n<oasis:entry>522.10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cryst syst</oasis:entry>\n<oasis:entry>monoclinic</oasis:entry>\n<oasis:entry>hexagonal</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>space group</oasis:entry>\n<oasis:entry>\n<italic>C</italic>2/<italic>c</italic>\n</oasis:entry>\n<oasis:entry>\n<italic>R</italic>3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>a</italic> (\u00c5)</oasis:entry>\n<oasis:entry>28.825(6)</oasis:entry>\n<oasis:entry>14.1755(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>b</italic> (\u00c5)</oasis:entry>\n<oasis:entry>11.472(2)</oasis:entry>\n<oasis:entry>14.1755(8)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>c</italic> (\u00c5)</oasis:entry>\n<oasis:entry>18.905(4)</oasis:entry>\n<oasis:entry>9.5058(11)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b1 (deg)</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b2 (deg)</oasis:entry>\n<oasis:entry>106.62(3)</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b3 (deg)</oasis:entry>\n<oasis:entry>90.00</oasis:entry>\n<oasis:entry>120.00</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>V</italic> (\u00c5<sup>3</sup>)</oasis:entry>\n<oasis:entry>5991(2)</oasis:entry>\n<oasis:entry>1654.2(2)</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>Z</italic>\n</oasis:entry>\n<oasis:entry>4</oasis:entry>\n<oasis:entry>3</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>D</italic>\n<sub>c</sub> (g\u00a0cm<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>1.402</oasis:entry>\n<oasis:entry>1.572</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03bc (Mo K\u03b1) (mm<sup>\u20131</sup>)</oasis:entry>\n<oasis:entry>1.260</oasis:entry>\n<oasis:entry>1.182</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>F</italic>(000)</oasis:entry>\n<oasis:entry>2488</oasis:entry>\n<oasis:entry>774</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>cryst size (mm)</oasis:entry>\n<oasis:entry>0.28 \u00d7\n0.26 \u00d7 0.24</oasis:entry>\n<oasis:entry>0.30 \u00d7 0.24 \u00d7 0.23</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\u03b8 range (deg)</oasis:entry>\n<oasis:entry>1.47 to 27.52</oasis:entry>\n<oasis:entry>2.71 to 27.52</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>limiting indices</oasis:entry>\n<oasis:entry>\u201336 \u2264 <italic>h</italic> \u2264 37</oasis:entry>\n<oasis:entry>\u201318 \u2264 <italic>h</italic> \u2264 12</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201314 \u2264 <italic>k</italic> \u2264\n14</oasis:entry>\n<oasis:entry>\u201318 \u2264 <italic>k</italic> \u2264 18</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry></oasis:entry>\n<oasis:entry>\u201323 \u2264 <italic>l</italic> \u2264 23</oasis:entry>\n<oasis:entry>\u201311 \u2264 <italic>l</italic> \u2264 10</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>data/restraints/params</oasis:entry>\n<oasis:entry>6603/6/305</oasis:entry>\n<oasis:entry>1579/1/91</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>GOF on <italic>F</italic>\n<sup>2</sup>\n</oasis:entry>\n<oasis:entry>1.072</oasis:entry>\n<oasis:entry>1.004</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>final <italic>R</italic> indices [<italic>I</italic> &gt; 2\u03c3(<italic>I</italic>)]</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>\n<xref ref-type=\"table-fn\" rid=\"t1fn1\"></xref>\n</oasis:entry>\n<oasis:entry>0.0526</oasis:entry>\n<oasis:entry>0.0199</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub>\n<xref ref-type=\"table-fn\" rid=\"t1fn2\"></xref>\n</oasis:entry>\n<oasis:entry>0.1798</oasis:entry>\n<oasis:entry>0.0428</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic> indices (all data)</oasis:entry>\n<oasis:entry></oasis:entry>\n<oasis:entry></oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>R</italic>\n<sub>1</sub>\n</oasis:entry>\n<oasis:entry>0.0647</oasis:entry>\n<oasis:entry>0.0199</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>\n<italic>wR</italic>\n<sub>2</sub>\n</oasis:entry>\n<oasis:entry>0.1944</oasis:entry>\n<oasis:entry>0.0428</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>largest diff. peak and hole(e\u00b7\u00c5<sup>\u20133</sup>)</oasis:entry>\n<oasis:entry>2.835 and \u22121.248</oasis:entry>\n<oasis:entry>0.417 and \u22120.252</oasis:entry>\n</oasis:row>\n<oasis:row>\n<oasis:entry>CCDC</oasis:entry>\n<oasis:entry>1554083</oasis:entry>\n<oasis:entry>1554084</oasis:entry>\n</oasis:row>\n</oasis:tbody>\n</oasis:tgroup>\n</oasis:table>\n<table-wrap-foot>\n<fn id=\"t1fn1\">\n<label>a</label>\n<p>\n<italic>R</italic>\n<sub>1</sub> = \u2211||<italic>F</italic>\n<sub>o</sub>| \u2013 |<italic>F</italic>\n<sub>c</sub>||/\u2211|<italic>F</italic>\n<sub>o</sub>|;</p>\n</fn>\n<fn id=\"t1fn2\">\n<label>b</label>\n<p>\n<italic>wR</italic>\n<sub>2</sub> = [\u2211[<italic>w</italic> (<italic>F</italic>\n<sub>0</sub>\n<sup>2</sup>\u2013 <italic>F</italic>\n<sub>c</sub>\n<sup>2</sup>)<sup>2</sup>]/\u2211[ <italic>w</italic> (<italic>F</italic>\n<sub>0</sub>\n<sup>2</sup>)<sup>2</sup>]]<sup>1/2</sup>.</p>\n</fn>\n</table-wrap-foot>\n</table-wrap>", "clean_text": "Table 1. Crystal Data and Structure Refinement for the Two MOFs\n\n|                    | MOF-In1                      | MOF-In2                      |\n|--------------------|------------------------------|------------------------------|\n| empirical formula | C<sub>42</sub>H<sub>33</sub>O<sub>20</sub>P<sub>2</sub>In<sub>3</sub> | C<sub>21</sub>H<sub>12</sub>O<sub>7</sub>PIn |\n| form wt            | 1264.08                      | 522.10                       |\n| cryst syst         | monoclinic                   | hexagonal                    |\n| space group        | C2/c                         | R3                           |\n| a (\u00c5)              | 28.825(6)                    | 14.1755(8)                   |\n| b (\u00c5)              | 11.472(2)                    | 14.1755(8)                   |\n| c (\u00c5)              | 18.905(4)                    | 9.5058(11)                   |\n| \u03b1 (deg)            | 90.00                        | 90.00                        |\n| \u03b2 (deg)            | 106.62(3)                    | 90.00                        |\n| \u03b3 (deg)            | 90.00                        | 120.00                       |\n| V (\u00c5<sup>3</sup>)  | 5991(2)                      | 1654.2(2)                    |\n| Z                  | 4                            | 3                            |\n| D<sub>c</sub> (g\u00a0cm<sup>\u20133</sup>) | 1.402              | 1.572                        |\n| \u03bc (Mo K\u03b1) (mm<sup>\u20131</sup>) | 1.260                 | 1.182                        |\n| F(000)             | 2488                         | 774                          |\n| cryst size (mm)    | 0.28 \u00d7 0.26 \u00d7 0.24            | 0.30 \u00d7 0.24 \u00d7 0.23            |\n| \u03b8 range (deg)      | 1.47 to 27.52                | 2.71 to 27.52                |\n| limiting indices  | \u201336 \u2264 h \u2264 37                 | \u201318 \u2264 h \u2264 12                 |\n|                    | \u201314 \u2264 k \u2264 14                 | \u201318 \u2264 k \u2264 18                 |\n|                    | \u201323 \u2264 l \u2264 23                 | \u201311 \u2264 l \u2264 10                 |\n| data/restraints/params | 6603/6/305               | 1579/1/91                    |\n| GOF on F<sup>2</sup> | 1.072                       | 1.004                        |\n| final R indices [I &gt; 2\u03c3(I)] |                            |                            |\n| R<sub>1</sub><sup>a</sup> | 0.0526                  | 0.0199                       |\n| wR<sub>2</sub><sup>b</sup> | 0.1798                  | 0.0428                       |\n| R indices (all data) |                            |                            |\n| R<sub>1</sub>       | 0.0647                       | 0.0199                       |\n| wR<sub>2</sub>      | 0.1944                       | 0.0428                       |\n| largest diff. peak and hole(e\u00b7\u00c5<sup>\u20133</sup>) | 2.835 and \u22121.248 | 0.417 and \u22120.252 |\n| CCDC               | 1554083                      | 1554084                      |\n\na R<sub>1</sub> = \u2211||F<sub>o</sub>| \u2013 |F<sub>c</sub>||/\u2211|F<sub>o</sub>|;\nb wR<sub>2</sub> = [\u2211[w (F<sub>0</sub><sup>2</sup>\u2013 F<sub>c</sub><sup>2</sup>)<sup>2</sup>]/\u2211[ w (F<sub>0</sub><sup>2</sup>)<sup>2</sup>]]<sup>1/2</sup>.", "data": [[{"meta": {"name": "MOF-In1", "symbol": "", "chemical formula": "C42H33O20P2In3"}, "chemical formula weight": [{"value": "1264.08", "unit": "", "condition": ""}], "crystal system": [{"value": "monoclinic", "condition": ""}], "space group": [{"value": "C2/c", "condition": ""}], "lattice parameters": [{"value": {"a": "28.825(6)", "b": "11.472(2)", "c": "18.905(4)", "alpha": "90.00", "beta": "106.62(3)", "gamma": "90.00"}, "condition": ""}], "cell volume": [{"value": "5991(2)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.402", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.28 x 0.26 x 0.24", "unit": "mm", "condition": ""}]}, {"meta": {"name": "MOF-In2", "symbol": "", "chemical formula": "C21H12O7PIn"}, "chemical formula weight": [{"value": "522.10", "unit": "", "condition": ""}], "crystal system": [{"value": "hexagonal", "condition": ""}], "space group": [{"value": "R3", "condition": ""}], "lattice parameters": [{"value": {"a": "14.1755(8)", "b": "14.1755(8)", "c": "9.5058(11)", "alpha": "90.00", "beta": "90.00", "gamma": "120.00"}, "condition": ""}], "cell volume": [{"value": "1654.2(2)", "unit": "\u00c5^3", "condition": ""}], "density": [{"value": "1.572", "unit": "g/cm^3", "condition": ""}], "crystal size": [{"value": "0.30 x 0.24 x 0.23", "unit": "mm", "condition": ""}]}]], "include_properties": ["chemical_formula", "chemical_formula_weight", "crystal_system", "space_group", "lattice_parameters", "cell_volume", "density", "crystal_size"], "intermediate_step": {"table-convert2MD": "[gpt.ft]Table 1. Crystal Data and Structure Refinement for the Two MOFs\n\n|                    | MOF-In1                      | MOF-In2                      |\n|--------------------|------------------------------|------------------------------|\n| empirical formula | C<sub>42</sub>H<sub>33</sub>O<sub>20</sub>P<sub>2</sub>In<sub>3</sub> | C<sub>21</sub>H<sub>12</sub>O<sub>7</sub>PIn |\n| form wt            | 1264.08                      | 522.10                       |\n| cryst syst         | monoclinic                   | hexagonal                    |\n| space group        | C2/c                         | R3                           |\n| a (\u00c5)              | 28.825(6)                    | 14.1755(8)                   |\n| b (\u00c5)              | 11.472(2)                    | 14.1755(8)                   |\n| c (\u00c5)              | 18.905(4)                    | 9.5058(11)                   |\n| \u03b1 (deg)            | 90.00                        | 90.00                        |\n| \u03b2 (deg)            | 106.62(3)                    | 90.00                        |\n| \u03b3 (deg)            | 90.00                        | 120.00                       |\n| V (\u00c5<sup>3</sup>)  | 5991(2)                      | 1654.2(2)                    |\n| Z                  | 4                            | 3                            |\n| D<sub>c</sub> (g\u00a0cm<sup>\u20133</sup>) | 1.402              | 1.572                        |\n| \u03bc (Mo K\u03b1) (mm<sup>\u20131</sup>) | 1.260                 | 1.182                        |\n| F(000)             | 2488                         | 774                          |\n| cryst size (mm)    | 0.28 \u00d7 0.26 \u00d7 0.24            | 0.30 \u00d7 0.24 \u00d7 0.23            |\n| \u03b8 range (deg)      | 1.47 to 27.52                | 2.71 to 27.52                |\n| limiting indices  | \u201336 \u2264 h \u2264 37                 | \u201318 \u2264 h \u2264 12                 |\n|                    | \u201314 \u2264 k \u2264 14                 | \u201318 \u2264 k \u2264 18                 |\n|                    | \u201323 \u2264 l \u2264 23                 | \u201311 \u2264 l \u2264 10                 |\n| data/restraints/params | 6603/6/305               | 1579/1/91                    |\n| GOF on F<sup>2</sup> | 1.072                       | 1.004                        |\n| final R indices [I &gt; 2\u03c3(I)] |                            |                            |\n| R<sub>1</sub><sup>a</sup> | 0.0526                  | 0.0199                       |\n| wR<sub>2</sub><sup>b</sup> | 0.1798                  | 0.0428                       |\n| R indices (all data) |                            |                            |\n| R<sub>1</sub>       | 0.0647                       | 0.0199                       |\n| wR<sub>2</sub>      | 0.1944                       | 0.0428                       |\n| largest diff. peak and hole(e\u00b7\u00c5<sup>\u20133</sup>) | 2.835 and \u22121.248 | 0.417 and \u22120.252 |\n| CCDC               | 1554083                      | 1554084                      |\n\na R<sub>1</sub> = \u2211||F<sub>o</sub>| \u2013 |F<sub>c</sub>||/\u2211|F<sub>o</sub>|;\nb wR<sub>2</sub> = [\u2211[w (F<sub>0</sub><sup>2</sup>\u2013 F<sub>c</sub><sup>2</sup>)<sup>2</sup>]/\u2211[ w (F<sub>0</sub><sup>2</sup>)<sup>2</sup>]]<sup>1/2</sup>.\n<END>", "table-categorize": "Crystal", "table-crystal-categorize": "```JSON\n[\n    {\n        \"meta\": {\n            \"name\": \"MOF-In1\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C42H33O20P2In3\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"1264.08\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"monoclinic\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"C2/c\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"28.825(6)\",\n                    \"b\": \"11.472(2)\",\n                    \"c\": \"18.905(4)\",\n                    \"alpha\": \"90.00\",\n                    \"beta\": \"106.62(3)\",\n                    \"gamma\": \"90.00\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"5991(2)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.402\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.28 x 0.26 x 0.24\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n    {\n        \"meta\": {\n            \"name\": \"MOF-In2\",\n            \"symbol\": \"\",\n            \"chemical formula\": \"C21H12O7PIn\",\n        },\n        \"chemical formula weight\": [\n            {\n                \"value\": \"522.10\",\n                \"unit\": \"\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal system\": [\n            {\n                \"value\": \"hexagonal\",\n                \"condition\": \"\",\n            },\n        ],\n        \"space group\": [\n            {\n                \"value\": \"R3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"lattice parameters\": [\n            {\n                \"value\": {\n                    \"a\": \"14.1755(8)\",\n                    \"b\": \"14.1755(8)\",\n                    \"c\": \"9.5058(11)\",\n                    \"alpha\": \"90.00\",\n                    \"beta\": \"90.00\",\n                    \"gamma\": \"120.00\",\n                },\n                \"condition\": \"\",\n            },\n        ],\n        \"cell volume\": [\n            {\n                \"value\": \"1654.2(2)\",\n                \"unit\": \"\u00c5^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"density\": [\n            {\n                \"value\": \"1.572\",\n                \"unit\": \"g/cm^3\",\n                \"condition\": \"\",\n            },\n        ],\n        \"crystal size\": [\n            {\n                \"value\": \"0.30 x 0.24 x 0.23\",\n                \"unit\": \"mm\",\n                \"condition\": \"\",\n            },\n        ],\n    },\n]\n```"}}, {"idx": 5, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch1\" position=\"float\">\n<label>1</label>\n<caption>\n<title>Syntheses Route of MOF-In1 and MOF-In2</title>\n</caption>\n<graphic id=\"gr1\" position=\"float\" xlink:href=\"am-2017-09227v_0006.tif\"></graphic>\n</fig>", "clean_text": " 1  Syntheses Route of MOF-In1 and MOF-In2   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 7, "type": "figure", "classification": null, "content": "<fig fig-type=\"scheme\" id=\"sch2\" position=\"float\">\n<label>2</label>\n<caption>\n<title>Preferred Coordination Strategy for Creating <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> and <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold>\n</title>\n</caption>\n<graphic id=\"gr2\" position=\"float\" xlink:href=\"am-2017-09227v_0007.tif\"></graphic>\n</fig>", "clean_text": " 2  Preferred Coordination Strategy for Creating 5-FU@MOF-In1 and Zn  2+  @MOF-In1    ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 9, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig1\" position=\"float\">\n<label>1</label>\n<caption>\n<p>\n<bold>MOF</bold>-<bold>In1</bold> showing (a)\n3D framework containing two types of channels (left, type A; right,\ntype B); (b) 3D topology structure; (c) natural tiling structure.</p>\n</caption>\n<graphic id=\"gr3\" position=\"float\" xlink:href=\"am-2017-09227v_0009.tif\"></graphic>\n</fig>", "clean_text": " 1   MOF-In1 showing (a) 3D framework containing two types of channels (left, type A; right, type B); (b) 3D topology structure; (c) natural tiling structure.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 13, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig2\" position=\"float\">\n<label>2</label>\n<caption>\n<p>\n<bold>MOF</bold>-<bold>In2</bold> showing (a)\n[InO\u00ad(CO<sub>2</sub>)<sub>3</sub>] hexagonal cage; (b) 2D layer; (c)\n3D framework; (d) 3D 2-fold interpenetrating diamondlike topology\nstructure.</p>\n</caption>\n<graphic id=\"gr4\" position=\"float\" xlink:href=\"am-2017-09227v_0010.tif\"></graphic>\n</fig>", "clean_text": " 2   MOF-In2 showing (a) [InO(CO2)3] hexagonal cage; (b) 2D layer; (c) 3D framework; (d) 3D 2-fold interpenetrating diamondlike topology structure.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 15, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig3\" position=\"float\">\n<label>3</label>\n<caption>\n<p>(a) UV\u2013vis spectroscopy of <bold>MOF</bold>-<bold>In1</bold> (black) and <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> (red). (b) Infrared spectroscopy of 5-FU, <bold>MOF</bold>-<bold>In1</bold>, and <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>.</p>\n</caption>\n<graphic id=\"gr5\" position=\"float\" xlink:href=\"am-2017-09227v_0011.tif\"></graphic>\n</fig>", "clean_text": " 3  (a) UV-vis spectroscopy of MOF-In1 (black) and 5-FU@MOF-In1 (red). (b) Infrared spectroscopy of 5-FU, MOF-In1, and 5-FU@MOF-In1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 17, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig4\" position=\"float\">\n<label>4</label>\n<caption>\n<p>SEM images\nfor (a) <bold>MOF</bold>-<bold>In1</bold> and (b) <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>, corresponding to the elemental mapping\nimage of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> for (c)\nthe indium element and (d) the fluorine element.</p>\n</caption>\n<graphic id=\"gr6\" position=\"float\" xlink:href=\"am-2017-09227v_0001.tif\"></graphic>\n</fig>", "clean_text": " 4  SEM images for (a) MOF-In1 and (b) 5-FU@MOF-In1, corresponding to the elemental mapping image of 5-FU@MOF-In1 for (c) the indium element and (d) the fluorine element.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 19, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig5\" position=\"float\">\n<label>5</label>\n<caption>\n<p>(a) Chemical shift change\nof 5-FU in <sup>19</sup>F NMR spectra (CD<sub>3</sub>OD, 243 K) of <bold>5-FU@MOF-In1</bold> with different molar fractions of 5-FU (\u03c7<sub>5\u2011FU</sub>). (b) Job plot between <bold>MOF-In1</bold> and\n5-FU in CD<sub>3</sub>OD at 243 K showing a maximum at 0.832. (c)\nHill function plot of log\u00ad[(1 \u2013 \u03b8)/\u03b8] vs log\u00ad[5-FU].</p>\n</caption>\n<graphic id=\"gr7\" position=\"float\" xlink:href=\"am-2017-09227v_0002.tif\"></graphic>\n</fig>", "clean_text": " 5  (a) Chemical shift change of 5-FU in 19F NMR spectra (CD3OD, 243 K) of 5-FU@MOF-In1 with different molar fractions of 5-FU (\u03c75-FU). (b) Job plot between MOF-In1 and 5-FU in CD3OD at 243 K showing a maximum at 0.832. (c) Hill function plot of log[(1 - \u03b8)/\u03b8] vs log[5-FU].   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 22, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig6\" position=\"float\">\n<label>6</label>\n<caption>\n<p>(a) Luminescence spectra of 5-FU releasing from <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> in PBS (pH 7.4) with time. (b) Release\nprocess of 5-FU from the <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold>.</p>\n</caption>\n<graphic id=\"gr8\" position=\"float\" xlink:href=\"am-2017-09227v_0003.tif\"></graphic>\n</fig>", "clean_text": " 6  (a) Luminescence spectra of 5-FU releasing from 5-FU@MOF-In1 in PBS (pH 7.4) with time. (b) Release process of 5-FU from the 5-FU@MOF-In1.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 24, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig7\" position=\"float\">\n<label>7</label>\n<caption>\n<p>\n<bold>MOF</bold>-<bold>In1</bold> and <bold>Zn</bold>\n<sup>\n<bold>2+</bold>\n</sup>\n<bold>@MOF</bold>-<bold>In1</bold> of (a) luminescence emission spectra; (b) X-ray photoelectron spectroscopy\nof O 1s; (c) infrared spectra; (d) PXRD patterns.</p>\n</caption>\n<graphic id=\"gr9\" position=\"float\" xlink:href=\"am-2017-09227v_0004.tif\"></graphic>\n</fig>", "clean_text": " 7   MOF-In1 and Zn  2+  @MOF-In1 of (a) luminescence emission spectra; (b) X-ray photoelectron spectroscopy of O 1s; (c) infrared spectra; (d) PXRD patterns.   ", "data": null, "include_properties": null, "intermediate_step": {}}, {"idx": 26, "type": "figure", "classification": null, "content": "<fig fig-type=\"figure\" id=\"fig8\" position=\"float\">\n<label>8</label>\n<caption>\n<p>(a) Release processes of <bold>5</bold>-<bold>FU@MOF</bold>-<bold>In1</bold> operated by competitive binding\nwith varied Zn<sup>2+</sup> concentrations with time at 37 \u00b0C;\n(b) comparison of release rate in different Zn<sup>2+</sup> concentrations.</p>\n</caption>\n<graphic id=\"gr10\" position=\"float\" xlink:href=\"am-2017-09227v_0005.tif\"></graphic>\n</fig>", "clean_text": " 8  (a) Release processes of 5-FU@MOF-In1 operated by competitive binding with varied Zn2+ concentrations with time at 37 \u00b0C; (b) comparison of release rate in different Zn2+ concentrations.   ", "data": null, "include_properties": null, "intermediate_step": {}}], "metadata": {"doi": "10.1021/acsami.7b09227", "title": "\nControlled\nZn2+-Triggered Drug Release by Preferred Coordination of\nOpen Active Sites within Functionalization Indium Metal Organic Frameworks\n", "journal": "American\nChemical Society", "date": "2017.08", "author_list": ["Du\nXi", "Fan\nRuiqing", "Qiang\nLiangsheng", "Xing\nKai", "Ye\nHaoxin", "Ran\nXinya", "Song\nYang", "Wang\nPing", "Yang\nYulin"]}}